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1 - Introduction 
 
Iron is a chemical element present in key biochemical processes of virtually every living cell. 
It exists in two interconvertible ionic forms, Fe2+ (ferrous ion, reduced) and Fe3+ (ferric ion, 
oxidized). This is the basis for numerous oxido-reductive electron transfers which are a vital 
element of living cells. The high reactivity of ionic iron, however, is also a danger, since it 
may lead to chemical radicals which are detrimental to biological macromolecules. An 
example for this is a reaction of the so-called Fenton type, where ferrous iron becomes 
oxidized by hydrogen peroxide. The reaction produces a hydroxyl anion and a hydroxyl 
radical, which can damage cell membranes and essential components like DNA or proteins. 
 
Fe2+ + H2O2 → Fe
3+ + OH· + OH− 
 
It is therefore important for the organism to exert a critical control over its free iron, otherwise 
its beneficial reactive characteristics can turn into a threat for the cell.  
 
In mammals, a very important role of iron is related to its presence in hemoglobin, a protein 
directly involved in oxygen transport through the body. The synthesis of hemoglobin is an 
essential step in the production of red blood cells (RBC). In the human body this step 
requires approximately 20 mg iron per day. In adult humans as well as in many other 
mammals the RBC production takes place predominantly in the bone marrow and 
represents the greatest demand of iron in the body. 
 
In the muscles, iron is present in myoglobin. This protein provides a reservoir of readily 
accessible oxygen. This is intracellular buffer for the case of intermittent anoxia [1]. Other 
cell types of the body contain iron as a reserve store, bound to ferritin. This protein is able to 
bind free iron in considerable amounts and keeps it non-toxic, releasing it only until required 
by other metabolic functions.  
 
Every cell of the body incorporates a certain amount of iron into a host of iron-containing 
proteins (heme proteins, Fe-S-cluster proteins) which fulfill essential functions of cellular life. 
 
The only natural source of iron for mammals is the diet. A tightly controlled mechanism 
exists to determine the exact amount allowed to enter the body. Disorders in this absorptive 
process, in either direction – too much or too little iron – have serious public health 
implications. Iron deficiency anemia is the most prevalent nutrition disease worldwide and 
affects every society, irrespective of race, cultural and social-background [2]. On the other 
hand is hemochromatosis a hereditary disease that provokes an excessive intake of iron 
from the diet. Since the human body is incapable of excreting iron in a well-regulated 
manner, an accumulation of this metal can take place, which damages the liver and other 
parenchymous organs and leads to liver cirrhosis and finally to liver cancer. The liver 
absorbs the excess of iron and so protects other organs, but unfortunately ends up 
damaging itself. 
 
In the brain, iron varies according to three factors: the anatomic region, the developmental 
stage of the organism and the species being studied [3]. In this organ iron plays a not-well 
characterized role. A strong correlation was observed between accumulation of this 
metabolite and neurodegenerative diseases like Parkinson, Alzheimer and Huntington [4, 5]. 
 




Uptake and distribution of iron in the body have been investigated in detail, but we have no 
complete picture of the molecular mechanisms that regulate these processes. There are still 
missing components that are at present being revealed through the use of modern 
molecular techniques. The use of transgenic mice technology opened a range of 
possibilities and helps to elucidate the regulatory pathways of iron metabolism. 
 
From a systemic point of view the iron metabolism displays two different hierarchical levels. 
One level concerns the well regulated iron metabolism within the multifarious types of cells 
and tissues of the body. The other level is the regulated exchange of iron between cells and 
tissues and the control of its uptake. The cellular and the organismal aspect are intimately 
connected and cannot be satisfactorily understood in isolation of each other. The study of 
isolated cells has led to a deeper understanding of the regulation within certain cells. 
However, the interpretation has been limited by the fact that the cell lines so studied were 
usually not fully functional and could not communicate with the extracellular environment 
and with other organs. On the other hand, the study of iron flux between tissues has led to 
important quantitative data, but was limited to a phenomenological level that described aptly 
what happened in the body, but not why it happened as it did. These two limitations have 
now been overcome by the modern gene construction techniques. They allow the study of 
animal iron metabolism applying certain well-designed genetic constructions which reveal, 
by knock-out or by enforced gene expression, the fine-tuning of iron-related reactions in the 
healthy as well as in the diseased organism. The so-called Cre-Lox-technology makes it 
even possible to change a certain gene in a selected target cell, by causing the attempted 
effect (knock-out, knock-in or enforced expression) only under the control of cell-specific 
promoters. So it became possible to address certain cell types and tissues with 
experimental changes, thereby avoiding the often deleterious effect of whole-body genetic 
mutations.  
 
A holistic understanding of iron metabolism in its various physiological and pathological 
states requires a deeper systemic understanding. This can be advanced by the method of 
mathematical modeling. Many ingenious mathematical studies of iron metabolism of the 
whole body have been published. Most of the earlier work concentrated on the interpretation 
of the tracer elimination curve in human blood plasma after an intravenous injection [6, 7]. 
Marsaglia, in cooperation with Finch and Hosain [8] devised a method to estimate the 
passage time through bone marrow and the return time of tracer into blood. Pollycove and 
Mortimer [9] published a study that tried to estimate the organ distribution of iron fluxes on 
the basis of scintillation measurements of tracer projected to the body surface. Nathanson 
and coworkers [10] studied the absorption and distribution kinetics of iron in dogs. Berzuini 
et al. [11] and later on Stefanelli et al. [12] developed whole-body models on data from 
human subjects, after tracer injection into blood or as colloidal tracer absorbed by the 
reticulo-endothelial system. A whole-body iron distribution study by Vácha et al. [13] 
attempted at a quantitative description of a mouse strain (C57BL/10ScSnPh) which is 
related to the strain to be modelled in this dissertation. This paper contained a series of 
ad-hoc assumptions on fluxes for which a precise biochemical characterization was not 
possible, but the resulting mathematical model fitted the measured ferrokinetic data quite 
satisfactorily. A first attempt to model iron metabolism as compartment system with inclusion 
of the recently discovered hormonal signals (especially the hepcidin loop) was published by 
Lao and Kamei [14]. The intracellular aspect has in all these papers been studied only in a 
black-box manner because iron motion within the cell occurs in a complex membranous 
environment. This precludes the classical biochemical kinetics which has been so 
successfully applied to the analysis of cytosolic and mitochondrial biochemistry.  
 
The dissertation presented here proposes a comprehensive description of iron metabolism 
in the form of an in silico simulation of the iron exchange and its regulation for the mouse 
strain C57BL6. We chose this special model animal for two reasons: It is the preferred strain 
for the afore-mentioned genetic constructs, and it is possible to obtain most of the 
experimental data that are required for a quantitative description of iron metabolism. A 
generic cell model will be presented which comprises the main features of iron metabolism 




that are common to all cell types, due to the fact that every cell expresses the same set of 
iron-related mRNA and proteins. Specific cellular flavor is obtained by adapting the values of 
certain crucial parameters of the cell model accordingly. The different cell and tissue types 
the iron profile of which is being specified in this way are then integrated in accordance with 
their relative abundance into a whole-body balance sheet to which the most important 
regulatory signals (iron-related hormone hepcidin, erythron-related hormone erythropoietin, 
intracellular regulators of the IRP/IRE system) are added. We show that certain of the salient 
features of iron metabolism in the normal state as well as under physiological or pathological 












2 - Models and Experimental Methods 
 
2.1 General Structure of Iron Metabolism 
 
Iron metabolism has been reviewed in several monographs from which the general structure 
can be extracted as basis for a mathematical model [15-17]. 
Iron is contained in every cell of the mammalian body and also in the extracellular space. 
Only tiny amounts appear as free ionic iron. All the other iron is in bound form, as 
hemoproteins, as oxygen carriers, as iron-sulfur proteins, in non-haem enzymes (such as 
transferrins), or as iron transporters in cellular membranes. 
 
 
2.2 General Flux Network of Iron in the Organism 
 
Mammalian organisms absorb iron from the intestinal tract, mainly via the duodenal 
epithelium, and loose it predominantly by exfoliation of intestinal epithelium, by 
desquamation of the skin, by occasional or repeated loss of blood, and to a lesser extent via 
excretion of a non-reabsorbed fraction of bile and urine. Duodenal absorption transfers iron 
into plasma where it is bound to transferrin. Transferrin-bound iron is distributed to 
peripheral tissues in accordance with their expression level of the transferrin receptor 
(TFR1). This stream into the periphery can be measured after injection of radioactive 59Fe 
into plasma as rate of appearance of the tracer in the periphery. This intake of iron into cells 
is balanced by an out- stream back into plasma of similar strength, mediated by iron export 
protein ferroportin [18]. 
This global scheme of iron uptake and distribution into the periphery and its reflux into 
plasma is adequately represented by a “mammillary” compartment system with reversible 
flux. The layout of the general flux model is depicted in fig. 2.1. 
 
Plasma and extracellular fluid contain transferrin-bound iron that equilibrates quickly (< 1 
day) between both compartments [6, 19], which are therefore treated as one central 
compartment. Other tissues form peripheral compartments. The erythropoetic compartment 
of bone marrow has a high expression level of the transporter TFR1 and rapidly integrates 
iron into hemoglobin [20, 21]. Both fluxes as well as the filtering-out of senescent blood cells 
are irreversible. In contrast, the expression level of ferroportin in bone marrow is low. This 
allows us to model the iron pathway from plasma over bone marrow, erythrocyte pool, and 
RES (emphasized by thick arrows in fig. 2.1) as a circular irreversible flux without reflux. A 
smaller flux from bone marrow into the Reticulo-Endothelial System (RES) has to be 
included. It represents partly spleen erythropoiesis in mice and partly “ineffective 
erythropoiesis” [22]. 






Figure 2.1: Global flux model layout. In green are shown the compartments representing each organ, the arrows 
are iron flows between compartments and plasma or directly between organs (bone marrow, RBC and Spleen). 
Dashed arrows represent fluxes that are known to exist but were omitted in our model because they were 
combined with the dominant outflux from the same compartment (to avoid parameter indeterminacy). 
 
 
Some of the peripheral compartments have two outlets, one leading back into the central 
compartment and the other one leaving the system by loss of cells or excretion. The 
clearance of radioactive tracer can be estimated in these cases, but not the partition 
between these two outlets. Loss of tracer from the body is difficult to measure, and the 
plasma curve is not sufficiently sensitive to small variants of back-flux from those tissues. 
For parameter estimation an a priori decision had to be made about which of the double 
outflows is quantitatively the more important. In the intestine and integument, with the 
exception of the duodenum, iron losses from the body are assumed to be the main route. 
This reflects the rapid exfoliation of intestinal epithelium (around 4 days), as well as the 
slower, but of larger volume, desquamation of skin and integumental adnexes. In the 
duodenum the 59Fe influx from plasma counters the physiological uptake of unlabelled iron 
from the lumen. In erythrocytes, liver, and kidney it was decided that the main pathway 
balancing iron uptake is reflux into plasma rather than loss out of the body.  
 
The compartments in fig. 2.1 represent organs and tissues. They are not kinetically 
homogenous, as every organ consists of cell types that may differ in their iron metabolism. 
Iron content in such compartments and intercompartment fluxes represent therefore a 








2.3 Iron balance: absorption from duodenum and loss from the body 
 
Iron is being distributed in various amounts over all body cells. The exchange traffic is 
mainly mediated via the transferrin pool in plasma (about 1.5 µg iron per mouse body). The 
absorption of iron takes place in the duodenal and upper jejunal lumen. The rate of 
absorption is tightly controlled and amounts to about 3 µg per mouse body per day. The 
adult healthy mouse is in a steady state, because the rate of iron loss is the same, 
amounting to 0.5% of the total body iron per day [23, 24]. This happens mainly through 
desquamation of skin cells, loss of hair, and shedding of stomach and intestinal mucosa. In 
our model it will be formulated as aggregated iron ‘leakage’ where the whole cell is lost from 




2.4 Numerical Scales of Pools and Turnover Rates. 
 
2.4.1 Scaling of iron content to the whole mouse organism 
 
The generic model of fig. 2.1 has to be quantitatively specified. The assumed reference 
organism of all data in this paper is an adult mouse of 25 g body mass; all other references 
are transformed to this scale. Comparing relevant data from other species involves a scale 
factor of approximately 10 from mouse to rat and 2500 to 3000 from mouse to humans. 
Compartments are envisaged as iron aggregates (“pools”) the iron content of which is a 
systemic variable, expressed in units of µg iron per animal. Fluxes into and out of a 
compartment are expressed in units of µg iron per animal per day.  
 
The systemic structure of this model is specified by “content” data (“concentration” of iron in 
its various biochemical forms in the different compartments), and by “turnover” data, usually 
obtained from tracer studies. Both data sets must be scaled up to the whole organism. The 
model must have a mathematical structure that reflects statics and dynamics. Its parameters 
are to be estimated from the empirical data. 
 
An important indicator of the iron status of cells or of the whole body is the iron content in the 
various biochemical fractions of iron.  
 
The quantitatively dominating biochemical form of iron in the mammalian body are:  
 as coordination atom in the heme group (ion haemoglobin, about 600 µg per 
mouse body; 
 in myoglobin, about 100 µg per mouse body;  
 minor contents in other cellular hemoproteins  
 non-heme iron (iron bound to ferritin, about 300 µg per mouse body; 
 other iron-containing proteins (e.g. FeS-cluster), small fraction of heme iron; 
 in blood plasma bound to transferrin (about 1.5 µg per mouse body)  
 
The biochemical status of free ionic iron in the cell is not quite clear. One fraction is called 
Labile Iron Pool (LIP), ([25]) can be extracted by chelating agents, and is said to the 
crossroads of biosynthetic and biodegrading pathways in the cell. Its concentration is very 
small in all cells, well below 1 µM, e.g. in liver [26]  
 
LIP can serve as theoretical indicator of the iron state in mathematical models. A better 
measurable indicator of cellular iron is the amount bound to ferritin, which can be extracted 








2.4.2  Contribution of organs and tissues to whole body mass 
 
An important scale factor is the fractional contribution of each organ or tissue to the mass of 
the whole body. Table 2.1 provides data for organ weights of C57BLC mice litter mates [27]. 
We include the estimates of plasma and blood volume of the whole body corrected for the 
bias of peripheral venous measurement [28].  
 
 
Table 2.1: The values were taken from [27]. Blood values were scaled to the whole body hematocrit according to 
[28]. It is being assumed that the organ weights do not considerably change between different dietary regimes in 
a healthy mouse. * Liver weight per mouse. Data from [27] ** Barbee et al. [29] give 2.3 ml / 25 g mouse *** Mass 
of bone marrow in mouse (body weight 23 g) calculated from Lee et al. [30] p.484) is 192 mg, here scaled up to a 
mouse body of 25 g. 
 
Organ weight in g per animal  
(ca 25 g)  
Standard 
deviation 
% of body weight 
Liver* 1.22 0.10 
             
     4.75 
Spleen  0.07 0.01      0.27 
Bones 1.80 0.25      7.01 
Heart 0.14 0.02      0.55 
Kidneys 0.38 0.05      1.48 
Lungs 0.13 0.05      0.51 
Stomach 0.18 0.04      0.70 
Intestine 1.22 0.19      4.75 
Duodenum 0.04 0.01      0.16 
Integument (fur) 3.97 0.73     15.50 
Fat 0.31 0.07      1.21 
Muscle 13.42 1.21     52.30 
Brain 0.47 0.01      1.83 
Testicles 0.24 0.07      0.94 
Plasma 1.36 0.03      5.30 
Blood cells  0.71 0.02      2.77 
Whole blood** 2.07 
           
0.04 
     8.07 
Bone marrow*** 0.21 0.03 
     
     0.84 
 
 
2.4.3 Upscaling of iron content to the whole organism  
 
To scale up the specific iron concentration (f, expressed as μg iron per g wet organ) to the 
total contribution of an organ or tissue compartment we multiplied such data by the total 
weight w (in g) of the organ(s) per body, i.e. f * w. The standard deviation was calculated 
from the standard deviations h(f) and s(w) of the factors according to the formula 2.23 on p.7 
of [31]: 
 
)s*hh*ws*(f SQR 222222    
 








2.5 Ferrokinetic study of tracer distribution 
 
As pointed out in the introduction it is intended to specify the model to the iron status of the 
mouse strain C57BL6. There are two basic sources of quantitative information available: 
biochemical assays of the “iron status” of the animal, and tracer-kinetic measurement of the 
fluxes between the iron compartments of cells and tissues. The former type of information 
has been assembled from a detailed study of the published literature on this mouse strain. 
The latter type of information was derived from experiments done in the laboratory of 
Professor K. Schümann, TU Munich, complemented again by literature data.  
 
 
2.5.1 Experimental Setting 
 
The data used for the model have been derived from ferrokinetic data [27]. In brief, male 
young adult mice (C57BL6 strain; 18-20 g) underwent a 5-week period (growth up to 25 g) 
with a diet controlled for iron content (iron content of diet induction of deficiency: 6 mg/kg; for 
adequate supply: 180 mg/kg; for iron overload 25000 mg/kg). The experiment was started 
by intravenous administration of ionic radioactive tracer (Fe59 nitrate in complex with 
nitrolotriacetic acid). It is known that this equilibrates quickly with the transferrin-bound iron 
pool [32]. The single tracer dose contained about 0.285 µg per mouse, which is less than 
2% of plasma iron and in the range of 0.01% of body iron. At certain intervals between 12 
hours and 28 days animals (n = between 3 and 7) were sacrificed, blood was collected and 
their main organs were dissected, weighed, and their iron status (non-heme iron) was 
measured. Hematocrit and haemoglobin content of blood were measured, and aliquots were 
separated into plasma and red blood cell compartment. The weight of organs and tissue 
samples was measured and normalized to the whole body (25 g). The ambient Fe59 content 
of organs and blood compartments was measured by scintillation counting and also 
converted to a whole body value. The tissue contents of tracer were corrected by 
subtraction of the tracer in the residual blood, by a calculation scheme that was derived from 
parallel model experiments with Fe59-labeled erythrocytes as indicator [27].  
All tracer data were corrected for the decay of radioactivity during the experiment by 
normalizing them with the help of the radioactivity of the injection solution measured at the 
same time.  
Data concerning the total iron clearance rate were obtained from Trinder et al. [33], as they 
were obtained on control mice of the same strain under very similar dietary regimes. 
 
 
2.5.2 Raw data corrected for blood content 
 
The raw data obtained from the experiments are given in (see Appendix A tables 1, 2 and 3). 
In iron-deficient mice the tracer content of the spleen dropped to zero after a short time and 
even reached apparent negative values. This is clearly an overcorrection for blood-related 
Fe59, as the spleen contains a large extravascular blood pool that cannot be removed 
completely by perfusion. The true tracer content of the splenic tissue was obviously close to 
zero at those time points (see Appendix A, table 1). Therefore, we set these small negative 
values equal to zero. This manipulation did not appreciably change the fractional clearance 
parameter of the iron-deficient spleen.  
 
 
2.5.3 Averaged tracer content in the intestine 
 
As the precise organ weights of intestinal subsections, such as ileum/coecum/colon were 
not established, we replaced the tracer concentrations in Appendix tables 1, 2 and 3 by a 
mean ascribed to the intestine as a whole. The standard deviation of this derived quantity 
was calculated according to the SQR-forluma sketched above. 
 




2.5.4 Normalization of the data set 
 
It is technically difficult to inject exactly the same small fluid dose of radioactive iron-solution. 
Therefore, the Fe59 content of an organ at a given time point was expressed as the Fe59 
concentration normalized according to the formula: 
 
Sum of radioactivity in the body at time t = 100% * exp h , 
 
were t is expressed in days. 
This describes the long-term rate of iron loss from the murine body [23, 24]. [34] give a 
somewhat lower rate of ~ 0.004 per day. The process of normalization smoothed the ups 
and downs of determined tracer contents. It indicates a loss of about 13% of the injected 
tracer over an experimental period of one month, which is in accordance with previous 
estimates (10-15%) [35]. 
 
 
2.5.5 Mathematical structure of the compartment model of tracer 
distribution 
 
The generic structure of the model is a set of balance equations describing time course and 
















Ci ( ≥ 0) - “pool size”: iron content of the i-th compartment, i = 1…n (number of pools) - 
chosen scale is μg per body  
vij ( ≥ 0) - rate of iron (in-) flux from compartment j to i (j = 1…n; j ≠ i ) (μg per body per day) 
vji ( ≥ 0) - rate of iron (out-)flux from compartment i to j (μg per body per day) 
vio ( ≥ 0) - rate of iron flux from outside the system into compartment i (μg per body per day); 
only influx into duodenum of “cold” iron has a value > 0  
voi ( ≥ 0) - rate of iron flux from compartment i out of the system (μg per body per day; values 
> 0 only for intestine, stomach, integument).  
 
 
2.5.6 Clearance mode of model description and derivation of motion 
equations. 
 
Each of the rates is a function of the status of some of the pool sizes and of kinetic 






















These coefficients describe the ambient tendency of a given flux to clear the pertinent 
source pool. They apply also to the dynamics of the tracer content. If fluxes and pool sizes 
do not change substantially during the experiment (steady-state of the bulk of “cold” iron 




fluxes and pools during the experiment by the tiny amount of tracer), the k´s become 
constant and a system of ordinary linear differential equations with constant coefficients 
describes the motion of the tracer content (x – being measured as specific radioactivity, i.e. 










   (i = 1…n)  
(3) 
 
where a term kio * xo has been dropped because re-absorption of excreted radioactivity can 
be neglected, if the tracer has been applied to the plasma compartment. The k-values for 
non-existing fluxes (out of the system or non-reversible) are set to zero. The system of 
differential equations describing the tracer motion is found in the next sections. 
 
 
2.5.7 Residence time 
 
Time scale is an important aspect of any metabolic model [102]. Interpretation of systems 
dynamics is simplified by introduction of expected residence times of molecules of defined 













2.6 System of Ordinary Differential Equations for Tracer Motion  
 
We established a mathematical description of the tracer content and the inter--
compartmental tracer flow using linear ordinary differential equations. This choice is justified 
as it can be assumed that pools and fluxes are approximately constant during the 
experiment. Under these conditions are the linear coefficients of tracer clearance constant 
quantities. The system of equations is shown below. For designations, refer to Figure 2.1. 
Parameter names in the computer program were assigned according to the convention ka_b, 
meaning clearance parameter of flux from a into b: 
 
d(Plasma) / dt = Plasma(t) * (-1kp_bon - 2kp_kid - 3kp_int - 4kp_liv - 5kp_sto -6kp_intg  
   
     -7kp_fat - 8kp_mus - 9kp_lun -10kp_duo - 11kp_brain - 12kp_hea  
     - 13kp_tes)     
   +14kkid_p * Kidneys(t) + 15kliv_p * Liver(t) + 16ksto_out * Stomach(t)  
   + 17kfat_p * Fat(t) + 18kmus_p * Muscle(t) + 19klun_p * Lungs(t)  
   + 20kbra_p * Brain(t) + 21khea_p * Heart(t) + 22ktes_p * Testes(t)  
   + 23kspl_p * Spleen(t) 
 
d(Bone Marrow) / dt = 1kp_bon * Plasma(t) -Bone Marrow(t) * ( 27kbon_rbc + 28kbon_spl) 




d(Liver) / dt = 4kp_liv * Plasma(t) - 15kliv_p * Liver(t) 
d(Spleen) / dt = - 23kspl_p * Spleen(t) + 29krbc_spl * RBC(t) + 28kbon_spl * Bone Marrow(t) 
d(Heart) / dt = 12kp_hea * Plasma(t) - 21khea_p * Heart(t) 
d(Testes) / dt = 13kp_tes * Plasma(t) - 22ktes_p * Testes(t) 
d(Lungs) / dt = 9kp_lun * Plasma(t) - 19klun_p * Lungs(t) 
d(Kidneys) / dt = 2kp_kid * Plasma(t) - 14kkid_p * Kidneys(t) 
d(Muscle) / dt = 8kp_mus * Plasma(t) - 18kmus_p * Muscle(t) 
d(Fat) / dt = 7kp_fat * Plasma(t) - 17kfat_p * Fat(t) 
d(Integument) / dt = 5kp_intg * Plasma(t) - 24intg_out * Integument(t) 
d(Duodenum) / dt = 10kp_duo * Plasma(t) - 26kduo_p * Duodenum(t) 
d(Stomach) / dt = 5kp_sto * Plasma(t) - 16ksto_out * Stomach(t) 
d(RBC) / dt = 27kbon_rbc * Bones(t) -29krbc_spl * RBC(t) 
d(Intestine) / dt = 3kp_int * Plasma(t) - 25int_out * Intestine(t) 
d(Brain) / dt = 11kp_brain * Plasma(t) - 20kbra_p * Brain(t) 
d(Outside) / dt = 25int_out * Intestine(t) + 26kduo_p * Duodenum(t)  
    + 24intg_out * Integument(t) 
 
At time = 0 the injection of a tracer dose (scaled to 100%) into plasma sets the boundary 
condition of this system (plasma (0) = 100% all other compartments = 0%). This sets a 
relaxation into motion that follows the fluxes of the bulk iron through the body.  
 
 
2.7 Parameter optimization pipeline 
 
With a system of linear ordinary differential equations representing the major ferrokinetic 
processes, the next step was to find reasonable parameters values that correctly described 
the physiological exchange of iron in the body. For this purpose we created an optimization 
pipeline (Figure 2.2). 





Figure 2.2: Optimization pipeline developed in this study. Starting with differential equations with arbitrarily 
chosen parameters the system is run and its results continuously compared to measurements. The difference 
between them is used by the optimization algorithm to improve the selection of parameters values for further 
runs. 
The first step was to create a system of linear ordinary differential equations and define 
reasonable initial parameter values, which were mainly derived from literature extracts. 
With this system of equations we produced simulated curves for each organ of our model 
(step number 1 in figure 2.2). We used an ODE solver from Matlab for stiff systems, since 
our system comprises different time scales, varying from minutes to days. 
We then compared the generated curves with real ferrokinetic measurements used as input 
for our model (step 2 in figure 2.2). Three different distance measures were tried: simple 
squared distance, squared distance divided by the standard deviation and squared distance 
divided by variance. Our experiments demonstrated that in our model the choice of one 
distance measure did not produce strong differences in parameter estimates, so we chose 
















where ije is the estimated value produced by our model, and ijm  is the measured value 
obtained from radioiron injection and std stands for the standard deviation of the measured 
point ijm . The index i runs from 1 to7 and corresponds to the 7 points of measurements in 
our experiments. The index j runs from 0-16 and corresponds to each organ of our system 
and experimental settings. 
We then estimated the parameters of the equation system in order to minimize the distance 
between the model curves and the measurements (step 3 in figure 2.2).  
The solution was to use a constraint optimization algorithm named Active-Set. This is a 
hill-climbing algorithm which receives as input: the initial parameter values and the system 
constraints. In our case only one constraint was defined, the sum of the parameters leaving 




the central compartment (Plasma) to the peripheral organs should be 20. This is based on 
the principle that the iron clearance time is below 1 hour in mice [33].  
 
 
2.7.1 Parameter Estimation by Convergence from different Starting Points 
 
The parameter optimization step was performed using as input the datasets with 
measurements of organ radioactivity under different diets. It was checked that the algorithm 
always converged to a parameter set giving an equal value of the distance minimum. In 
order to test the statistical uncertainty of these parameter estimates we randomly perturbed 
the measured compartment radioactivities within the measured standard deviations around 
their mean values. This change was performed for every measurement in the three datasets 
and the optimization pipeline of figure 2.2 executed. This complete procedure was repeated 
100 times for each dataset. 
 
 
2.7.2 Quality of final fit 
 
As an intuitive measure of the quality of the final fit we chose the root of mean of squared 
weighted deviation between prediction and the mean of measurements (table 3.2; “sq root of 
mean weighted squared dev”). We document the parameter set of the best fit together with 
an upper and lower bound obtained from a sextile-truncated sample of the empirically found 
parameter variation. In the case of a Gaussian distribution the interval thus defined would be 
twice the standard deviation.  
 
 
2.7.3 The problem of interdependence of parameter estimates 
 
Some parameters or sets of parameters are not identifiable by measurement in a model of 
given design. For instance, if ferrokinetic measurements are available only for the time 
course of changes in plasma concentration of tracer, the total clearance rate can be 
adequately assessed, but not the distribution into the network of body compartments. In 
contrast, if the first measurement was obtained after most of the tracer has left the plasma 
compartment, the relative distribution to the various organs can be assessed, but the flux 
dynamics of this distribution cannot. Even if parameters seem to be identifiable in the 
Laplace domain [36], the error structure of the data will make the ensuing algebraic 
treatment ill-conditioned and will expand the range of parameter estimates. They become 
meaningless. We tackled this problem by studying the parameter space using the 
alternating conditional expectation algorithm (ACE) [37, 38].  
The essence of this strategy is to explore the total domain with all parameter values that 
support an acceptable fit, i.e. the criterion value of this fit is sufficiently close to the optimum. 
This is done by running a large number of parameter estimations from a large range of 
starting points. The result is a set of sometimes widely differing parameter vectors that yield 
very similar optimal values of the fit criterion. Interdependent and hence non-identifiable 
parameter combinations can be addressed by the information furnished by the ACE method. 
On the basis of this analysis one or more suitable parameters are chosen to be fixed or held 
in definite proportion to each other so that the other parameters became identifiable. The 
choice of suitable parameters for this reduction of parameter redundancy and of their fixed 
values is not always easy and requires a theoretical understanding of the dynamic structure 
of the model. Maiwald et al. [39] have developed software (“Potter´s wheel”) the tools of 
which support this computer-time-intensive study very effectively. Specific assumptions 
made to remove strong parameter intercorrelation will be mentioned explicitly below.  
 
 




2.8 Flux rates and pools sizes derived from clearance parameters 
 
2.8.1 Calculation of absolute flux rates from fractional clearances 
 
The tracer data alone can be used to estimate fractional clearance parameters (per day) of 
flux out of plasma (ki_plasma). To calculate flux rates (µg per day per mouse) one needs the 
iron content of plasma plus extracellular fluid (Cplasma/ECF):  
         
    C * k       v plasma/ECFi_plasmai_plasma   (6) 
 
The iron pool of the plasma plus ECF is calculable from the iron concentration and the 
plasma volume plus the accessible volume of ECF. 
 
 
2.8.2 Estimation of peripheral pool size from countercurrent clearance 
parameters and plasma pool 
 
The iron content of body organs can be measured by chemical methods, mainly as 
hemoglobin, myoglobin, and non-heme iron. Cellular heme iron content as oxidoreductases 
and other proteins is less important quantitatively. Such direct measurements may be 
contrasted with tracer-accessible iron pool sizes. When in the steady-state influx and outflux 
are equal, the following equation relates the pool size Ci of a peripheral compartment to that 
of plasma 
 
  C * k     C * k iplasma_iplasma/ECFi_plasma   (7) 
 
If the data support estimates of the two rate constants (ki_plasma defining the early phase and 
kplasma_i characterizing the late phase of tracer distribution) and of the plasma/ECF iron 
content, then the size of the “accessible” pool Ci may be inferred. 
 
 
2.8.3 Scaling of the system variables and parameters  
 
All parameters and variables were scaled to be dimensionless. On rescaling to the in-vivo 
state variables and fluxes were transformed to units of µg per mouse (24 g) and µg per day 
per mouse, respectively. Turnover times and the inverse of related kinetic constants are 
expressed in days. 
 
 
2.9 The Cellular Model of Iron Metabolism 
 
So far we obtained a description of the physiological distribution of iron in mice. It aims at 
estimation of the cellular iron pools and iron fluxes between organs in the steady-state of the 
whole organism. In this section the layout a kinetic description of the iron turnover within and 
between cell types of the organism will be developed with the goal of predicting the 
steady-state of the whole organism of the mouse as a result of kinetic interaction of iron 
species in different cell types. The model will also comprise the most important regulatory 
mechanisms of iron metabolism. It will be based on quantitative literature data concerning 
the fine-tuning of iron metabolism. For obvious reasons it is not feasible to formulate such a 
model on the most elementary molecular and cell-biological level. This is because most 
types of kinetic measurements cannot be done on the intact tissue or cell in its natural 
environment. The reductive approach of experimental cell biology therefore provides in 
many cases qualitative data (molecular “mechanisms”), but no quantitative description. It will 
however be feasible, on the basis of existing physiological data and the established network 
structure of iron metabolism to derive a description of the core regulatory structure of the 
system. 





The mechanistic skeleton of iron metabolism is very much the same in each cell type, 
because the genes and their products are the same. We therefore derive a generic model of 
iron metabolism within the cell. The specificity of tissue and cell types will be introduced in 
addition by modifying parameters of the regulatory structure of this generic model. Such 
core parameters are the iron status and the expression level of iron-related mRNA and/or 
protein of a specialized cell type. 
 
 
2.9.1 Transfer across the cell membrane 
 
 Transferrin-mediated iron uptake: Most part of iron is taken up by the cells through 
transferrin-receptor-1 mediated endocytosis [40]. The transferrin molecule, when it 
carries two iron atoms (apotransferrin) binds to the surface receptor and after 
conformational changes the complex is internalized. The iron molecules are released 
into the cell and the unloaded complex returns to the cell surface. To determine the 
kinetic constants involved in this process a pioneer study was conducted by 
Ciechanover [41]. Using HepG2 cells they determined the amount of surface receptors 
and the rate at which each step of the transferrin internalization cycle happens. We used 
those values to derive parameter values for the pertinent kinetic equations of this thesis 
 Non-Transferrin-mediated iron uptake: In addition to the iron that enters the cell 
through the transferrin-transferrin receptor cycle, there is a certain amount of this 
metabolite that is taken up by the cells through other mechanisms. The duodenum 
absorbs iron from the diet by reduction from ferric to ferrous ion (calculated by the 
cytochrome b-like ferrireductase (Dyctb) and ensuing uptake by the divalent metal 
transporter 1 (DMT1). This surface receptor is expressed mainly in the brush border 
membrane of duodenal cells and is also responsible for the absorption of other metals. 
In addition, hepatocytes are able to take up iron molecules from blood that is not bound 
to transferrin. 
 




2.9.2 Intracellular processes 
 
 Ferritin as Storage Compartment: Once inside the cells, it is believed that iron 
molecules appear in the so-called Labile Iron Pool (LIP). The exact physicochemical 
status of this pool is not known except but it can be extracted and quantified by chelating 
agents [25] The amount of iron present as LIP is much smaller than that bound to ferritin. 
This protein is able to store up to 4500 iron atoms in one molecule. There exist two 
isoforms of this protein (Light and Heavy chains), of different expression in different cells 
and with different storing capacities. In our simplified model we do not make a kinetic 
distinction between them and combine them to one storage pool. 
 
 Biosynthesis of cellular proteins: incorporating iron in prosthetic groups. These 
proteins are being synthesized in each growing cell and undergo turnover with specific 
time course in each cell. Two basically different subgroups of proteins may be 
distinguished. 
 
 Synthesis of Fe-S cluster: The Fe-S cluster is present in more than a hundred different 
proteins and it plays an important role in different processes inside the cell.  
 
 Heme Synthesis: The heme group in hemoglobin, myoglobin and a number of further 
proteins contains ferrous iron as catalysator. We include the hemoglobin pool in the 
erythropoetic system (in bone marrow and in red blood cells), the myoglobin pool mainly 
in red in muscle and a further unspecified combined pool of heme compounds in every 
other cell of the organism. 
 
 Iron Export from the Cell: The only known exporter of ionic iron out of the cell is the 
ferroportin molecule. The expression level of ferroportin is regulated by the hormone 
hepcidin which is produced in the liver and then transported in the blood plasma to the 
sites of its regulatory effect. The molecular mechanism of its effect is exerted by binding 
to ferroportin thereby triggering its intracellular degradation. Ferroportin is expressed at 
high level in duodenum, liver and macrophages, but to a lesser extent also in most or all 
other cell types [18]. 
 
 IRP Regulation: Iron Regulatory Proteins have a dual role in the cell: either binding to 
the 3’ end of mRNA molecules and thus stabilizing them against degradation or binding 
to the 5’ region of the mRNA and consequently inhibiting translation. Whether one or the 
other function happens depends on the iron level in the cell (LIP level) and on the 
presence of iron responsive elements (IRE) in either the 3’ or the 5’ ends of the mRNA 
molecules [40]. In our model the two different IRP proteins are represented as different 
pools. They protect the mRNA of transferrin receptor 1 and DMT1 against degradation 
and inhibit the translation of the apoferritin, ferroportin mRNA and the translation of other 
biosynthetic pathways (into Fe-S-Cluster and heme synthesis). We take both basic 




2.10  Iron flux network 
 
2.10.1 Intracellular and transmembrane iron flux 
 
The fig. 2.3 depicts how the different elements of intracellular iron metabolism interact with 
each other. The figure refers to a generic cell, i.e. to a cell that contains the main elements 
present in every body cell. Some special features of cell types that have a special role in iron 
metabolism are also sketched.  
 
The upper part of the picture shows the transferrin cycle (fluxes v1, v2, v3 and v4) as 




present in almost every cell. Depicted on the the left side is the iron uptake by DMT1 (v5) 
which is expressed in duodenal cells, as well as non-transferrin-mediated iron uptake (v7) 
which happens mainly in hepatocytes. 
Iron taken up by the mechanisms modelled as v1, v5 and v7 is further transferred into the 
Labile Iron Pool (LIP) (fluxes v3, v6 and v7). 
LIP iron molecules undergo four possible fates: stored in ferritin (w1), deployed in heme 
synthesis (w9), biosynthesis of Fe-S cluster (w3), and export by ferroportin transferred onto 
holotransferrin (w5 and w6). Stored iron may be mobilized (flux w2). Also iron bound in Fe-S 
clusters are re-utilized during the general protein turnover occurring with different time 
course in all cells that do not undergo cell loss. Heme iron may only be reutilized (w12) if the 
cell expresses the corresponding catabolic pathways (e.g. RES macrophages). Iron taken 
up into the erythropoetic pathway in bone marrow is converted to hemoglobin and added to 
the red blood cell compartment (w10). Red blood cells become senescent after a certain 
functional lifetime and the heme is transferred to macrophages of RES. There exists also a 
direct shuttle from bone marrow to RES [22] which has been explained as “ineffective 
erythropoesis”.  
At last, on the right side of the picture, is a leakage term which is used to represent the iron 
loss of the system due cell death and removal, mainly of intestinal epithelium and skin and 
other integument cells. Since labile iron pool is present only in tracer amounts, this leakage 
will visibly affect only the holoferritin level, which is in equilibrium with LIP.  
 
 
Figure 2.3: The figure shows the general cellular model shared by all organs in the model. What distinguished 
the cell-types are the parameter values defined for the equations. There are three pathways of iron input in the 
cell: TfR1 cycle, dietary uptake through DMT1 and non-TF bound iron. Inside the cell iron has some possible 
fates: be stored within ferritin, be exported to blood plasma by FPN1, participate in heme synthesis, be part of 
Fe-S clusters or in the case of bone marrow, be transferred directly to RES, due ineffective erythropoiesis. 
 
 
2.11 Regulated turnover of iron-processing macromolecules 
 
The macromolecules taking part in the regulatory scenario of this cellular model undergo 
continuous biosynthesis and degradation. This involves gene transcription into mRNA, 
translation of mRNA into protein and, after a certain characteristic life time within the cell, the 
degradation of mRNA catalyzed by RNAse and of proteins by the protein-degrading 




machinery of the cell. We simplify the enormous complexity of these processes by 
formulating for each protein an overall rate of biosynthesis and a rate of degradation. The 
latter is assumed to be proportional to the ambient cellular expression level. Both processes 
are influenced by kinetic signals of specific regulatory factors. The different levels of 
regulation (e.g. transcription regulation by a signal cascade involving plasma iron and 
hepcidin, or translation of mRNA into protein regulated by the IRP machinery) are integrated 
into these two overall rates. Figs. 2.4a and 2.4b illustrate how the aggregation of the mRNA 
and protein level together with a qualitatively equivalent transformation of the regulatory 




Fig. 2.4: a) EPO increases transcription of TFR1-mRNA in bone marrow; IRP stabilizes mRNA and thereby 
indirectly increases TFR1 expression level. b) Hepcidin increases degradation of ferroportin protein; IRP inhibits 
translation of ferroportin mRNA, so indirectly decreasing ferroportin expression level 
 
 
Figure 2.5 shows the cellular processes of steady macromolecular synthesis and steady 
decay that were implemented in this model. The “u” arrow stands for the integrated rate of 
translation and translation of a certain protein, whereas “z” represents the rate of 
degradation of a given protein. 
 
Included in this schematic picture is the IRP regulation. In the case of TfR1 and DMT1 the 
IRP proteins inhibit m-RNA degradation and hence enhance protein synthesis indirectly by 
the increased level of the mRNA.  
 
In the case of ferroportin, apoferritin and other cellular iron proteins the IRP system inhibits 
the translation of mRNA, thereby reducing the rate of synthesis of the respective protein in 
the cell. The Labile Iron Pool (LIP) plays a significant regulatory role as intracellular signal of 
the iron status. The exact nature of the iron signal is not known, but there is evidence that 
the LIP is correlated with it. The key regulator IRP1 protein has two states: active and 
inactive. The LIP has a stimulatory effect in the transition of the IRP1 protein from active to 
inactive state. When there is plenty of iron in the cell the synthesized Fe-S clusters bind to 
the IRP1 protein and convert it to a cytosolic aconitase which is not able to exert its role as 
an iron regulatory protein (reviewed in [40]). 
In the case of the second regulator IRP2 it is not a conversion between states that is 
regulated but rather the degradation rate of this protein in the cell. Therefore in our model 
LIP has a positive effect on the degradation of IRP2. 
One important aspect of our model concerns the descriptive combination of the IRP1 and 
IRP2 proteins in order to formulate an indicator variable “IRP effective”. The “division of 
labor” between these two closely related versions of intracellular iron regulation is not 
completely clear. We represent the two proteins here as a “pool” of IRP and posit a 
combined effect of the IRP´s, represented by a simple formula:  
 




IRP = IRP1act/ IRP1reference + IRP2 / IRP2reference 
 
where IRP1act stands for the active part of the expression level of IRP1, and IRP2 stands for 
the total expression level of the protein. The reference parameters allow for different 
activities of the two versions, the empirical basis of which is the fact that knockouts of IRP1 
in mice are lethal and those of IRP2 are not lethal, but lead instead to an iron storage 
disorder [42]. The transition for active IRP1 into its inactive aconitase form is taken into 
consideration as rapid equilibrium, whose position is influenced by the level of the labile 
cellular iron pool (as well as by other physiological parameters like oxygen level, H2O2 and 
NO levels). [43, 44]. 
 
 
Control via synthesis or via stabilization of mRNA and via translation 
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Fig. 2.5: This is a simplified scheme of the turnover of the iron-processing proteins in the generic cell. The 
transcription/translation process is represented in aggregated form by arrows and fluxes dubbed u (with index) 
and the decay process by arrows and rate variables z. The latter refer either to proteases or RNAses that remove 
the respective iron-processing proteins or their mRNA precursors. The lower-case letters at the macromolecules 
refer to the variable names of the differential equation system.  
 
 
Some processes are subject to global regulation by hepcidin. Hepcidin expression is 
regulated by the iron saturation level of plasma transferrin (symbolized as a direct 
stimulation of hepcidin synthesis). Hepcidin enhances the degradation of ferroportin 
predominantly in RES and duodenum, also in liver. It leads to a rapid internalization of 
membrane-resident ferroportin (f0 into f2) with slower proteolytic degradation afterwards.  
 
EPO has a positive stimulatory effect on the synthesis of TfR1 in bone marrow. The 
synthesis of EPO is negatively regulated by the levels of RBC: when the RBC level is high, 
there is no need for EPO, when RBC level diminishes, more EPO is synthesized to stimulate 
erythropoiesis. 
 
All these processes tend towards a steady state ( u = z) which is reached after a 
characteristic time set by the ratio of ambient protein level / cellular degradation rate. 
 




2.12 Nomenclature: variables and rates 
 
Table 2.1 summarizes the molecular elements and table 2.2 describes the fluxes in the 
model. Every organ has the same basic set of fluxes and the same set of differential 
equations; what distinguish them are the kinetic parameter values relating to the expression 
level and its regulation. There is only one transferrin synthesis and degradation term for the 
whole system (table 2.3), because the carrier protein transferrin is mainly synthesized in the 
liver and not in other cells.  
 
Table 2.1: Species shared by all cell-types in the model. The exceptions are Hepcidin, EPO, RBC and transferrin 
(0, 1), which are defined once for the whole system. 
 
Symbol Description 
α TFR1 on cell membrane surface 
β TFR1 / holoTF complex on cell membrane surface 
γ TFR1 / holoTF complex internalized 
δ TFR1 / apoTF complex in membrane 
0 apo TF in plasma 
1 holo TF in plasma 
λ LIP (labile intracellular iron pool) 
0 apoferritin 
1 holoferritin (with iron) 
s FeS cluster 
f0 free ferroportin exporter in cell membrane 
f1 iron-loaded ferroportin exporter in cell membrane 
f2 ferroportin in inactive form 
h heme level in cell 
m0 DMT1 as duodenal entry of iron, and as activator of holoTF/TFR1-processing in the 
lysosomes 
m1 iron-binding state of DMT1 
y0, y1  IRP1 level, in active and inactive form 
y2 IRP2 level 
EPO Erythropoietin 
Hep Hepcidin level 
RBC Circulating red blood cells, iron content 
 
Table 2.2: Model fluxes. This are the essential operations which involve transfer of ionic iron between different 
model parts, e.g. from outside the cell to inside or from LIP to apotransferrin. They are depicted in figure 2.3. 
 
Flux Description 
yeff effective activity of IRP system 
w1 uploading LIP iron on apoferritin 
w2 mobilization of ferritin iron into LIP 
w3 synthesis of FeS cluster 
w4 decay of FeS cluster protein, liberation of iron into LIP 
w5 uploading LIP iron onto ferroportin 
w6 export of iron onto apotransferrin (via FP) 
w9 heme synthesis 
w10 heme degradation 
w11 flow of iron between the bone marrow and RES (ineffective erythropoiesis 
w12 Return of iron from heme to LIP (catabolism) 
w13 iron loss due epithelial cell desquamation (skin / intestine) 
v1 binding of holoTF (plasma) onto TFR1 (membrane) 
v2 internalization of TFR1 / holoTF complex 
v3 release of iron into LIP from TFR1 
v4 return of apoTF into plasma & TFR1 onto membrane surface 
v5 TFR1-independent inflow of iron into certain cells 
v7 Non-transferrin or DMT1-mediated iron uptake 




Table 2.3 summarizes the turnover rates of macromolecules (synthesis and degradation). It should be noted that 
the elements in this table also contain the index “i” which refers to the different cell types (tissue types). 
 
Symbol Description 
ui1 translation of IRP1-mRNA 
ui2 translation of IRP2 –mRNA 
ui3 translation of TFR1 –mRNA 
ui4 translation of DMT1-lyso – mRNA 
ui5 translation of ferroportin mRNA 
ui6 translation of apoferritin-mRNA (in liver) 
ui7 synthesis of apo-transferrin 
zi1 Decay of IRP1-mRNA 
zi2 Decay of IRP2 –mRNA 
zi3 Decay of TFR1 –mRNA 
zi4 Decay of DMT1– mRNA 
zi5 Decay of ferroportin mRNA 
zi6 Decay of apoferritin-mRNA 
zi7 Decay of plasma transferrin 
 
 
2.13 Balance equations 
 
We derive the kinetics of iron interaction within and between cell types of the body according 
to the following general concept: 
o stoichiometric structure of the main reactions in the form of balance equations 
describing the iron transfer between biochemically defined entities 
o aggregation of quantitatively minor biochemical reactions of the same type (e.g. cellular 
heme protein) 
o bilinear kinetics of iron binding to iron carrier proteins and translocators 
o signalling superstructure by effector terms in rate equations 
o formulation of dynamics in terms of ordinary differential equation systems  
 
These is a kinetic “hybrid” model (in the spirit and wording of [45]). For practicability 
purposes we combine simplified rate laws as basis of the model and insert special terms for 
signalling effects.  
 
 
2.13.1 Balance equations in the plasma compartment 
 
In the central compartment the transferrin-bound iron and the hormones hepcidin and 
erythropoietin are dispatched to their effector locus.  
 
d0/dt = u7 - z7 + Σi (v i4 – wi6) apo-transferrin 
d1/dt =  v0 +Σi (wi6 – v i1)  holo-transferrin 
 
The indexed fluxes have the following meaning:  
v i1 - entry of holo-transferrin into the endocytotic cycle 
v i4 – release of apo-transferrin after endocytotic deloading of iron 
wi6 - transfer of cellular iron onto apo-transferrin (ferroportin-mediated)  
 
The index i applies to the cell/tissue types: 
 i=1: bone marrow,  
 i=2: liver 
 i=3: RES 
 i=4: muscle 
 i=5: integument 
 i=6: intestine 
 i=7: duodenum 




 and the sum Σ is defined for the w6 and v1 of the respective cell type or tissue. 
 
dHEP / dt = u8 – z8   hepcidin  
dEPO / dt = u9 – z9   erythropoetin 
 
 
Balance equations in the blood cell compartment 
 
dRBC / dt = w10 - wRBC 
 
 
2.13.2 Balance equations in the cell, with cell type parameter specification 
 
Fig. 2.2 symbolizes the events within the generic cell and its borders. We now write down 
the balance equations pertinent to this scheme. The individual rate equations for special cell 
types will be derived below, but we indicate in bracket if a flux applies only to certain cell 
types (i.e. has a non-zero value only for the cell types indicated in bracket). The 
designations are defined in tables 2.1-2.3 (apo- and holo- applies to free and iron-loaded 
entities, respectively). 
 
d0 / dt = w2 – w1 + u6 – z6 apo-ferritin 
d1 / dt = w1 – w2 holo-ferritin 
df0 / dt = u5 – za5 – w5 + w6 apo-ferroportin 
df1 / dt = w5 – w6 holo-ferroportin 
df2 / dt = za5 – z5 ferroportin for degradation 
(phosphorylated) 
dm0 / dt = u4 – z4 + v6 – v5 apo-DMT1 
dm1 / dt = v5 – v6 holo-DMT1 
dα / dt = u3 – z3 + v4 – v1 TFR1 in membrane 
d β / dt = v1 – v2 holo-TF-TFR1 in membrane 
d γ / dt = v2 – v3 holo-TF/TFR1 internalized 
d δ / dt = v3 – v4 apo-TF/TFR1 in membrane 
dy1 / dt = u1 – z1 IRP1 
dy2 / dt = u2 – z2 IRP2 
ds / dt = w3 - w4  
dh / dt = w9 - w10 (bone marrow) - w12 – w11  
 
The expression for cellular free iron (LIP) reads 
 
d λ / dt = v3 – w1 + w2 – w3 + w4 – w5  
       + v6 (duodenum only) + v7 (liver only) - w9 (bone marrow & muscle) 
- w11 (bone marrow) + w12 (muscle only) - w13 (integument & intestine)  
+ (wshunt + wRBC) (RES only) 
       
 
 
2.14 Rate equations of iron transfer between iron-processing proteins 
 
Kinetic theory of biochemical catalysis in aqueous dilution is not applicable to iron 
metabolism. Iron occurs in coordinated states bound to carrier protein or in complex as 
component of prosthetic groups (e.g. heme). The kinetic description was therefore chosen in 
terms of on- and off- rate constants times the cellular content (“concentration”) of respective 
reactants of a transfer or binding reaction. For the transferrin-receptor-mediated endocytosis 
a kinetic theory was obtained from data on isolated cells [41]. We assume that the time 
characteristics of intra-cellular iron transfer is of the same range for all metabolically active 
cells. Variables are scaled to dimensionless quantities, setting them equal to unity in what 
we call the reference state of the organism (adult male mouse, 25 g, on adequate iron diet). 




Tissue contents of ferritin (“non-heme iron”) were available from the literature and from 
measurements of Schümann et al. [27], as were flux rates between tissue compartments 
after analysis of ferrokinetic data. These quantitative data can be converted to 
tissue-specific kinetic rate parameters. We applied power-rate laws in some cases, when 
the subsystems of iron transfer or endocrine signalling to cells have a high logarithmic gain 
in vivo (i.e. small relative concentration changes lead to high relative effects).  
 
 
2.15 Kinetic Description of Iron-Transfer and Regulatory Signals 
 
The cell manages ferrous iron in bound form, attached to specialized carrier proteins, such 
as ferritin. Iron-containing prosthetic groups (such as heme group) are bound to protein 
carriers. Uptake and secretion of iron is also catalyzed by proteins which organize the 
transfer of iron into and out of the cells. Plasma iron is bound to the transport protein 
transferrin. All these processes take place in a cellular or membrane medium where the 
methodology of kinetic analysis in biochemistry with its concepts of “concentration” and 
“steady-state enzyme kinetics” are applicable at best by loose analogy. Well-known methods 
to achieve this are the methods of approximate kinetic formalisms [46, 47]. In effect, these 
concepts allow for a quantitative description of metabolic turnover that integrates the 
mechanistic molecular detail as black-box which is assumed to be in a dynamic steady state. 
[46-52] 
Many of the iron-transfer reactions take place within a narrowly restricted range of 
“concentrations” of the partaking components. We introduce expansions (linear for protein 
turover, bilinear for iron processing, power law for reguatory signals) of the complex rate 
laws which are approximately valid in the neighborhood of a generic reference state, which 
is conceived as an idealized model of the “normal” healthy organism. All iron-processing 
proteins are assumed to exist in an iron-free and an iron-bound state (e.g. apoferritin and 
holoferritin), the sum of both being fixed at a given moment. This ensures that there are 
upper and lower constraints to the rates in the simplified kinetic description. 
 
For convenience of controlling different simulation runs with systematic parameter variation 
we adopted a formulation of the bi-linear kinetics of reversible binding reactions as 
reversible rates with kon and koff as rate parameters:  
 








free protein carrier + occupied protein carrier = ambient expression level of protein carrier. 
 
The signal cascades operating in iron metabolism involve a number of components to which 
the details of the accepted biochemical formalism cannot be specified. In contrast to the 
kinetic formalism of metabolic transfer the black-box formulation of the signaling cascades 
has to include an amplifier mechanism, because otherwise the operational gain of a signal 
(log final effect /log effector level) becomes very small at the end of a long and branched 
cascade. Regulatory cascades in vivo have inbuilt strong amplifier mechanisms (sometimes 
even to the extent of an all-or-none effect), but we will not produce this by meticulous 
formulation of details, but rather choose a general black-box formula in the form of a simple 
power rate law. For an activator signal we adopt the representation  
 
activator signal = (activator level / Kapp)
 n   
 
and for an inhibitor signal: 





inhibitory signal = (Kapp / effector level))
 n  
 
The effector levels and the signal strength are expressed in dimensionless form and 
included into the rate equations for the respective reaction. The term Kapp (= apparent) refers 
the ambient effector level to that of the idealized (“normal”) reference state. The exponent n 
realizes the required amplifier gain. This particular form of signal kinetics was chosen for the 
sake of ensuring that the logarithmic gain of activator and inhibitor signals of different 
regulatory loops is symmetric and may be qualitatively related to each other by choice of the 
apparent kinetic parameter Kapp and the logarithmic gain factor n. For illustration, consider 
the fate of a macromolecule x which is synthesized and degraded by a steady-state 
dynamics:  
→ x → 
If there is an activator effect operative enhancing the expression level of x, this can be 
achieved either by an activator term (act) on the input reaction 
 
dx/dt = 0 = U * act – Z * x with stationary x = U * act / Z 
 
or, equivalently (when there is no information on the precise molecular mechanism) by an 
inhibitor term (inh) on the output reaction 
 
dx/dt = 0 = U – Z * x * inh with stationary x = U / (Z * inh) 
 
Equivalence of both effects is only given if 
 
act = 1 / inh  
 
With a logarithmic gain of n this requires that  
 
act = (effector / Kapp)
n  and inh = (Kapp / effector)
 n 
 
Any of the usual Hill or allosteric equations for activation and inhibition cannot guarantee this 
equivalence. For the sake of comparison of interacting global and cellular signals we chose 
therefore this simple form. It guarantees that the reference state of the system (arranged to 
effector/Kapp=1) does not change when different n-values are tested for efficiency. And it 
guarantees that activation of one partial reaction is symmetric to inhibition of the other partial 
reaction involving synthesis and decay of an effector, so that quantitative comparison of 
effector strength becomes possible, with Kapp and n as modifying parameters. In numerical 
simulations one must take care of not falling into regions far from the reference state where 
the simple formula is no longer even qualitatively valid (e.g. approach of positive or negative 
infinity of the ratio).  
 
 
2.16 Modelling the hepcidin effect on ferroportin expression 
 
Hepcidin is being synthesized in the liver and reaches the locus of its signalling effect via 
plasma. Effector cells are mainly duodenum, macrophages of RES and hepatocytes. 
Hepcidin interacts with the membrane-resident ferroportin and causes its internalization, 
which is then followed by intracellular proteolytic degradation. From hepcidin injection 
experiments it is known that the internalization occurs rapidly (within a few hours [53, 54], 
whereas the ensuing proteolytic degradation has the general time characteristics of several 
days. This regulation was therefore modelled as depicted in fig. 6. 
 






Fig. 6: Hepcidin increases degradation of ferroportin protein by binding and internalizing.  
 
The balance equations of this subsystem read  
 
df0/dt = u5 – z5a – w5 + w6 
df1/dt = w5 – w6 
df2/dt = z5a – z5 . 
 
Assuming linear kinetics one gets 
 
z5a = Z5a * f0 * hepact   
z5 = Z5 * f2  
 
(hepact is the kinetic activation term of hepcidin level)  
 
and for the steady state 
f0 = u5 / (Za5 * hepact) 
f2 = u5 / Z5 
f1 is proportional to f0 , depending on cellular iron and free plasma transferrin  
(λ and {τ0 / (τ0+τ1)} 
 
 
2.17 Rate equations of iron uptake and iron release by the cell 
 
v1 = K1 * α * τ1 (K1 = 0.4; calculated from [41]) 
v2 = K2 * β (K2 = 0.1; calculated from [41]) 
v3 = K3 * γ * m1 (K3 = 0.05; calculated from [41]) 
v4 = K4 * δ (K4 = 1.25; calculated from [41]) 
v5 = K5 * m0 (K5 = 2.5; iron in intestinal tract) 
v6 = K6 * m1 (K6 = 2.5; iron uptake via DMT1) 
v7 = K7 (K7 = 0.5; parameter for non-TFR1 iron 
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2.18 Rate equations of internal transfer 
 
w1 = H1 * φ0 * λ (H1 = 10) 
w2 = H2 * φ1 (H2 = 1) 
w3 = H3 * λ * / Yeff ^ q3 (H3 = 5; q3 = 1; signal Yeff see below) 
w4 = H4 * s (H4 = 5) 
w5 = H5 * λ * f0 ^ 3 (H5 = 1.8) 
w6 = H6 * f1 * τ0 (H6 = 2.4) 
w9 = H9 * λ / Yeff ^ n9 (H9 = 20.1 in bone marrow; 2.22 in muscle 
else=0; n9 =1) 
w10 = H10 * h (H10 = 18.1 bone marrow; else = 0) 
w11 = H11 * h (H11 = 2.0 bone marrow; else=0; w11 identical 
to wshunt) 
w12 = H12 * h (H12 = 2.2 in muscle heme turnover ) 
w13 = H13 * λ (H13 = 1.65 in integument ; 1.35 in intestine) 
wRBC = kRBC * RBC/ RBCref (kRBC = 18.1; RBCref = 1) 
 
The parameters of wRBC were derived by normalization. The actual reference pool size of 




2.19 Rate equations of combined transcription/translation (protein 
biosynthesis) 
 
u1 = U1 (U1 = 1) expression of IRP1 
u2 = U2 (U2 = 1) expression of IRP2 
u3 = U3 * epo ^ nepo * yeff ^ n3 (n3 = 1, nepo=5) expression of TFR1 
Tissue U3 Parameter value in different cell types 








The EPO activation term is only valid for the bone marrow, for the other organs it is to be 
cancelled out. The U3 values were calculated from ferrokinetic flux estimates (see below, 
results). RES does not receive iron over the TFR1-pathway, but rather by phagocytosis of 




u4 = U4 * yeff ^ n4 (U4 = 1; n4 =1) expression of DMT1 
u5 = U5 / yeff ^ n5 (U5 = 0.5; n5 =1) expression of ferroportin 
u6 = U6 / yeff ^ n6 (n6 =1) expression of apoferritin 
Tissue U6 Parameter value in different cell types 












u7 = U7 (U7 = 1) expression of transferrin 
u8 = U8 * (1/( 1+ 0) / 0.15 - 1.0) (U8 = 0.3) expression of hepcidin, descriptive 
formula calculated from figure 1 of [55]) 
u9 = U9 * (RBCref / RBC) ^ n9 (U9=1; RBCref =1; n9 =4) (expression of 




2.20 Rate equations of protein degradation 
 
z1 = Z1 * y1 (Z1 = 1) degradation of IRP1 
z2 = Z2 * y2 * λ ^ n2 (Z2 = 1; n2 = 3) degradation of IRP2 
z3 = Z3 * α (Z3 = 2) degradation of IRP1 
z4 = Z4 * m0 (Z4 = 1) degradation of DMT1 
z5 = Z5 * f2 (Z5 = 0.5) degradation of ferroportin 
za5 = Za5 * f0 * hepact internalization of ferroportin 
tissue Za5 Parameter value in different cell types







z6 = Z6 * φ0 (Z6 = 1) degradation of ferritin 
z7 = Z7 * τ0 (Z7 = 1.33) degradation of transferrin 
z8 = Z8 * hep (Z8 = 0.2) excretion of hepcidin 
z9 = Z9 * epo (Z9 = 1) degradation of erythropoietin 
 
 
2.21 Kinetics expressions for autocrine and endocrine signalling 
 
Active IRP1: Y1_act = Y1 / λ ^ 3 (LIP inactivates IRP1)  
 
Combined effect of IRP-system, with IRP2 dominating and the IRP1 equilibrium poised 
towards aconitase in the reference state; [56]) 
 
Yeff = Y_act/ Y1reference + Y2 / Y2reference (Y1_reference = 20;Y2_reference = 1.0526) 
 
Erythropoetin signalling to bone marrow: 
 
epoact = epo ^ nepo   (nepo = 5) 
  
Hepcidin signalling to RES, liver, duodenum, activating ferroportin degradation: 
 
hepact = hep ^ nhep  (nhep = 3) 
 
 




2.22 Parameter portrait to simulate physiological or pathological deviation 
 
Parameter portraits plot the steady-state value of system variables against systematic 
changes of one or several of the parameters. This simulates physiological challenge or 
genetic perturbation of the basic reference state. The dynamic stability of the steady-state 
was checked as return to it after a series of random-perturbations of variables and, in critical 
cases, by evaluating the eigen-system around the steady-state.  
 
 
2.23 Numerical solution of dynamic systems (ordinary differential 
equations) 
 
With parameter values and the initial state of variables specified the dynamics of approach 
to steady-state was calculated using MatLab integration routines, mainly a Runge-Kutta 
algorithm.  
The attainment of steady-state was checked by calculating the absolute values of right-hand 
sides of the differential equations divided by the level of the corresponding variable. A 










3 - Results 
 
3.1 Plasma Iron Pool 
 
The iron pool in blood plasma, despite its importance as the main iron exchange medium in 
the vertebrate body, has a small size compared to other pools (1-2 μg Fe per mouse) and is 
renewed several times per day (table 3.1). 
The table shows that the transferrin-bound plasma iron concentration varies according to 
the iron status in the body. It tends to be lower under an iron deficient diet and higher in iron 
loaded conditions. It is in the range of 80-150 μg/dL and is similar to other mammalian 
species [57-61]. In rats, iron deficiency does not seem to lower plasma iron concentration. 
 
TABLE 3.1: 1) Molecular weight of iron 55.847 2) 1.36 ml plasma per 25 mg mouse (see table 2.1) 3) Rounded 
value of row 4 * 55.847 / 1000 *1.36 ml (body plasma volume) 
 
 Fe-Deficient Fe-Adequate Fe-Loaded 
Plasma iron concentration [μM] 15.2 ± 5.5 19.8 ± 1.4 25.8 ± 1.0 
scaled t [μg/dL] 1  84.0 110.5 144.1 
Plasma pool size [μg per mouse] 2 1.15 1.50 1.96 
Plasma iron turnover rate [μM/day] 
(PIT) 139 185 245 
Scaled to μg per mouse3 11 14 19 
Total clearance rate [d-1] 17.2 18.1 18.8 
Plasma half-life time of iron [min] 58 55 53 
 
 
The Plasma Iron Turnover rate is an indicator of how much iron is cleared from plasma per 
day. Iron molecules leave the plasma and go to peripheral organs and in our model iron 
molecules either slowly return to plasma to be again distributed through the organism or are 
lost due mucosal or skin desquamation. The Plasma Iron Turnover is calculated as follows: 
 
PIT = 10 [per day] * plasma concentration [μM] – 13 [μM per day]. 
 
the slope of 10 and the intercept of -13 were estimated from fig. 5 of [33]. Like the plasma 
iron concentration, the PIT increases in an iron-loaded diet and diminishes under 
iron-deficient conditions. 
 
The total clearance rate from table 3.1 is calculated by the plasma turnover rate and plasma 
iron concentration, taken from fig. 5 of [33]. In their study turnover was measured at 2 h after 
administration assuming that the exponential clearance rate constant is given by 
 
-24/2 * ln {1 - (turnover rate) / (plasma concentration) * 2/ 24}  
 
This estimate is probably somewhat too low due the influence of tracer reflux. For parameter 
estimation we therefore rounded this preset value to maximum of 20 per day. To assess the 
precise total clearance rate would be necessary to perform measurements in groups of mice 
in a short period right after radioiron injection. This was not done in our experiments, since it 




is not feasible in mice. Our first measurement was performed at 12h, when most part of 
injected radioiron was already cleared from plasma. Cavill et al. have summarized the 
corresponding problems in humans [62, 63]. 
With the calculated turnover rate constants it is possible to estimate the half-life of 
transferrin-bound plasma iron as follows: 
 
Half-life = ln (2) / turnover rate constant [per day] * 24 * 60 [min]) 
 
The half-life of transferrin-bound plasma iron is somewhat slower for the iron deficient diet 
(58 minutes) and somewhat faster for iron-loaded diet (53 minutes). These values are in the 
same range from other species like dogs and rats [10, 59, 60] and in accordance with 
other studies [33, 64]. 
 
 
3.1.1 Tracer uptake into murine Organs 
 
Schümann´s tracer data [27] (see appendix A) allow to estimate clearance parameters of 
their compartment representation, see table 3.2. These parameters can be used to 
understand what proportion of the initial injected radioiron dose is absorbed by the organs 
and later returned to plasma. As mentioned previously, for our optimization purposes it 
was established that the sum of the fractional rates leaving the plasma was set to 20 per day. 
Figure 3.1 depicts how many percent of this fixed value is distributed among organs of mice 
under different dietary conditions. 
 
 
Figure 3.1: distribution of radioactive plasma iron between organs. There are two different scales: one for the 
organs known to have a high iron storage or demand like liver and bone marrow and a second scale with 
peripherical organs like the testicles, heart and brain. The percentage values depicted were calculated as 
follows: The best-fit clearance parameters for flux plasma-organ for the respective diet were divided by the total 
(=20) and multiplied by 100. 




TABLE 3.2: Clearance parameter rates for the best fit and also the upper and lower limits obtained after Monte Carlo perturbations of the measurement values followed by the curve-fit procedure. 
This sequence was performed 100 times. The dimension of the data is day-1. The + and – indicate statistically valid change compared to iron-adequate diet (bracketed if only slight). 
    Fe-Deficient      Fe-Adequate     Fe-Loaded   




Best Fit Lower Limit Upper Limit Best Fit Lower Limit Upper Limit 
1kp_bon   13.22 12.47 13.63  12.67 12.01 13.26 6.92 6.01 7.09   + 
2kp_kid   0.42 0.28 0.54  0.45 0.36 0.51 1.62 1.18 1.82   + 
3kp_int   0.98 0.77 1.06  0.9 0.63 1.1 0.93 0.66 1.01 
4kp_liv   2.27 1.83 2.54  2.61 2.28 2.9 5.25 4.25 5.73   + 
5kp_sto   0.09 0.06 0.18  0.12 0.08 0.17 0.27 0.21 0.37   + 
6kp_intg   1.04 0.89 1.32  1.14 0.96 1.35 1.33 1.05 1.50 
7kp_fat   0.04 0.03 0.05  0.05 0.04 0.05 0.066 0.051 0.075  (+) 
8kp_mus   0.96 0.8 1.23  -  1.49 1.31 1.8 2.52 2.06 2.75   + 
9kp_lun   0.79 0.64 1.06  +  0.31 0.22 0.44 0.63 0.56 0.75   + 
10kp_duo   0.02 0.01 0.15  0.04 0.03 0.06 0.038 0.027 0.050 
11kp_bra   0.03 0.03 0.03  0.03 0.03 0.04 0.021 0.019 0.022  - 
12kp_hea   0.11 0.1 0.14  0.13 0.12 0.15 0.36 0.31 0.38   + 
13kp_tes   0.04 0.04 0.05  0.06 0.05 0.06 0.043 0.037 2.68 
14kkid_p   0.2 0.11 0.32  0.2 0.14 0.25 0.23 0.16 0.32 
15kliv_p   0.25 0.21 0.32  +  0.14 0.11 0.16 0.10 0.073 0.12   (-) 
16ksto_out 0.18 0.09 1.72  0.37 0.27 0.49 0.29 0.20 0.40 
17kfat_p   0.1 0.06 0.19  0.13 0.1 0.15 0.099 0.079 0.12 
18kmus_p   0.03 0.02 0.05  -  0.15 0.12 0.21 0.14 0.11 0.17 
19klun_p   0.41 0.37 0.52  +  0.19 0.11 0.3 0.086 0.065 0.12   (-) 
20kbra_p   0.02 0.02 0.03   -  0.06 0.05 0.07 0.028 0.022 0.034  - 
21khea_p   0.06 0.03 0.08   (-)  0.08 0.06 0.09 0.17 0.14 0.19   + 
22ktes_p   0.05 0.03 0.07   -  0.09 0.07 0.12 0.067 0.044 7.16 
23kspl_p   14.61 13.86 15   -  7.29 5.53 9.15 1.91 1.52 2.33   - 
24kintg_out 0.03 0.02 0.05  0.04 0.03 0.06 0.072 0.057 0.102  (+) 
25kint_out   0.3 0.22 0.4  0.36 0.26 0.42 0.22 0.16 0.26   - 
26kduo_p   0.17 0.12 2.55  0.42 0.32 0.55 0.24 0.18 0.34 
27kbon_rbc 1.85 1.74 1.92   +  1.07 0.93 1.26 0.50 0.48 0.57   - 
28kbon_spl 0.56 0.4 0.83   +  0.1 0.08 0.13 0.046 0.033 0.058  - 
29krbc_spl 0.03 0.02 0.04   -   0.06 0.05 0.07 0.032 0.027 0.047  - 
            
fval chi_sqr 0.58       0.72     1.05     
sq root of mean 
weighted squared dev 0.07     
  
0.08     0.07   
  
- 




Considering the two different scales of figure 3.1 (0-2% and 0-70%) we observe that there 
were organs which did not demonstrate a strong difference in terms of tracer iron uptake 
between the diets: brain, fat, testicles, intestine and integument. In the case of duodenum, 
stomach and lungs it is not possible to affirm that there is a representative difference on the 
iron uptake levels. This can be attributed to technical difficulties associated to the organ size 
(duodenum, stomach) or the lack of cellular homogeneity of the organ itself (lungs). 
On the other hand, it is visible that other organs have a great difference in tracer uptake 
levels when the mice were held under different diets. The heart and the muscles absorb 
around 2 times more iron under loading scenarios. In contrast, in the iron-loaded diet the 
bone marrow absorbs around 30% less in comparison to iron-deficient or -adequate. This 
difference in absorption in the bone marrow, liver and muscles reflects a “switch” to a 
storage mode that occurs in the organism when there is iron repletion. 
 
Figures 3.2, 3.3 and 3.4 show the tracer distribution among organs during the study period 
under the three different diets. We can observe from the figures and numerically assess 
from tables 1-3 in Appendix A that at the time when the first measurement was performed 
(12h) the plasma radioiron clearance was already complete. The tracer had been already 





Figure 3.2: The best fit of our model to the measured data of mice held under iron adequate diet. The blue dots 
with standard deviation are the measurements and the red line of the curve produced by our model. 






Figure 3.3: The best fit of our model to the measured data of mice held under iron deficient diet. The blue dots 















Figure 3.4: The best fit of our model to the measured data of mice held under iron loaded diet. The blue dots with 
standard deviation are the measurements and the red line of the curve produced by our model. 
 
The two components in the plasma curve (first exponential decay and later a small tracer 
level close to zero) can be attributed to i) the first clearance phase (which happens 
approximately within one hour [33] and ii) to a reflux of iron from the organs to the plasma. 
Inspection of the organ curves demonstrate that after 12-24 hours the reflux into plasma 
starts to take place and follows until the end of the study. In addition, from the same figures it 
is possible to verify that the organs receive radioiron and store for biosynthetic functions, 
return it to plasma to be redistributed among other organs or looses it by desquamation, as 
is the case of intestine and integument. 
In addition, the influx and outflux of radioiron from the organs obviously take place 
simultaneously, in accordance with the steady-state experienced during the development of 
this study.  
The results presented so far related to iron uptake by the organs were expressed as percent 
of the injected tracer dose. To have a more precise quantitative description of the amounts 
exchanged by the organs and present the results in units that can be further used for 
comparison among species, one should use absolute flux rates. 
To calculate the absolute flux rates it is necessary to have the fractional clearance rates 
(table 3.2) and the iron content of plasma plus the extracellular fluid (table 3.1). 
We calculate the flux rates (vplasma_i) as: 
 
 




vi_plasma = ki_plasma * Cplasma/ECF 
 
where ki_plasma is the fractional clearance rate between plasma into the organ i and Cplasma/ECF 
is the iron content in plasma plus extracellular fluid. 
We can observe in figure 3.5 and table 3.3 that three sets of flux rates may be distinguished: 
 flux through the erythron (range of 10 to 20 µg / day per mouse) 
 flux through peripheral compartments with storage function (liver, muscle, integument, 
intestinal tract, kidneys, lungs, heart: 0.5 to 4 µg / day per mouse) 













Table 3.3. The calculations were done for the “best-fit” parameters. 
 
 Absolute Flux Rates (μg/body/day) 
Parameter Fe-Deficient Fe-Adequate Fe-Loaded 
1kp_bon 15.19 19.007 13.55 
2kp_kid 0.48 0.66 3.17 
3kp_int 1.12 1.34 1.83 
4kp_liv 2.61 3.92 10.29 
5kp_sto 0.105 0.18 0.53 
6kp_intg 1.19 1.71 2.602 
7kp_fat 0.05 0.067 0.13 
8kp_mus 1.106 2.24 4.93 
9kp_lun 0.907 0.45 1.22 
10kp_duo 0.021 0.064 0.075 
11kp_bra 0.032 0.048 0.041 
12kp_hea 0.132 0.202 0.71 
13kp_tes 0.046 0.082 0.084 
14kkid_p 0.48 0.66 3.17 
15kliv_p 2.61 3.92 10.29 
16ksto_out 0.105 0.182 0.53 
17kfat_p 0.05 0.067 0.13 
18kmus_p 1.106 2.24 4.93 
19klun_p 0.907 0.457 1.22 
20kbra_p 0.032 0.048 0.041 
21khea_p 0.132 0.202 0.71 
22ktes_p 0.046 0.082 0.084 
23kspl_p 15.19 19.007 13.55 
24kintg_out 1.19 1.71 2.602 
25kint_out 1.12 1.34 1.83 
26kduo_p not calculated not calculated 
not 
calculated 
27kbon_rbc 11.66 17.36 12.42 
28kbon_spl 3.53 1.63 1.13 
29krbc_spl 11.66 17.36 12.42 
 
 
3.1.2 The Erythropoietic System 
 
The injected radioiron in plasma is cleared after approximately 1 hour and most part of its 
molecules is routed to the bone marrow. Due the intensive production of hemoglobin, the 
erythrocyte production path represents the greatest iron demand [20, 21]. According to 
figures 3.1, 3.5 around 63% of iron is taken up by the bone marrow under normal conditions 
and 66% under iron deficiency. The value obtained here seems to be lower than in other 
species [6, 21, 65]. 
 
Under iron-loaded diet the uptake by the bone marrow is decreased to just 35%, that is 
about half of normal uptake. In figures 3.1, 3.5 it is possible to see a switch of the system 
into a storage mode [66]. This increases the amount of iron absorbed initially by the liver and 
muscles and diminishes the iron to be used in the erythrocyte forming pathway. A 
corresponding, but slight, decrease in hemoglobin synthesis was observed under this iron 
loaded condition [27].  
 
Some days after injection, for all three conditions, saturation behavior can be observed on 
the red blood cell curves (figures 3.2, 3.3 and 3.4). In iron-deficient and iron-adequate mice, 
around 60% of the injected radioiron dose is present as hemoglobin in the red blood cells, 




and in iron-loaded mice, just 40%. 
This saturation behaviour instead of a continuously increasing curve suggestsrandom 
elimination of red blood cells (independent of cell age), in addition to the normal lifespan 
removal. The bone marrow receives daily an influx of 15;19;14 µg iron (table 3.3). Without 
this random destruction component, radioiron that returned from other organs would be 
continuously further incorporated into red cells. 
Horký et al. [67] studied the red cell lifespan and developed an age independent linear 
component of cell destruction. This linear element in combination with a life-span 
determined component produced a rate of red cell elimination of 0.012 per day. Our value is 
higher: between 0.03 and 0.06 per day. However, these values rely on estimated pool sizes, 
therefore they are not totally reliable. 
 
After about 30 days the red blood cells are senescent or damaged and need to be removed 
from circulation, so their iron molecules are liberated and used in the synthesis of new 
healthy erythrocytes. The murine spleen has a dual role: both removing red cells and 
colloidal iron from circulation [9, 68] or as an erythropoietic organ [64]. 
The spleen contains 5% of the total macrophage population and depending on body iron 
status the spleen either releases or stores iron originated from the red cell destruction. Table 
3.2 shows that under iron deficient diet the spleen releases back to plasma approximately 
14.6 splenic pools per day while under iron loaded conditions, this amount decreases to just 
1.91 pool units per day. 
Another source of iron for the spleen is provided by ineffective erythropoiesis, especially 
under iron deficiency, when the demand for iron increases. Under iron scarcity many 
erythrocytes are synthesized in the bone marrow receiving less than the appropriate amount 
of iron to be functional [68]. These red cells do not reach the final stage of maturation and 
are cleaned from blood by the macrophage system. Table 3.2 shows that the rate of transfer 
between the bone marrow and spleen increases 10 times between iron-deficient and 
iron-loaded and 5 times between iron-deficient and iron- adequate conditions. This is 
evidence that the spleen releases iron based on body status or stores it either as ferritin or 
hemosiderin [69]. 
It is important to mention that in our model there is no distinction between the macrophage 
populations and therefore RES is mentioned interchangeably with spleen (figure 2.1). To 
understand the precise role of macrophage population in each organ would be necessary to 
carry a cell separation, which is known to be technically very difficult [68]. 
The erythropoietic contribution of the spleen is a minor factor in terms of body iron turnover 
and erythropoesis. From tables in 1-3 in Appendix A it can be observed that the amount of 
iron absorbed by the spleen after 12 hours is not high. The ratio between the tracer content 
of bone marrow and spleen after 12 hours is respectively 50, 60 and 20 in iron-adequate, 
-loaded and -deficient mice. 
 
 
3.1.3 Compartment size of Tracer-Accessible Peripheral Pools 
 
The compartment sizes in our model were estimated inorder to calculate the size of the 
“tracer-accessible pools”. This should reflect the behavior of newly absorbed molecules 
whichcan be either stored, used for cellular functions of returned to plasma. 
Under steady state assumption, to calculate the tracer accessible pool sizes we need to be 
aware of: 
 the fractional clearance rates from plasma into a compartment (ki_plasma) and also from 
that compartment back to plasma (kplasma_i). 
 the plasma/ECF iron concentration (Cplasma/ECF). 
With these values, we use equation (7). 
Comparing the diets, it can be observed in table 3.4 and figure 3.6 that under iron-loaded 
diet the amount of absorbed and possibly stored radioiron is increased in every organ 
considered. 
 




We can see from table 3.4 (and depicted in fig. 3.6) that the pool sizes can be group mainly 
into three groups: 
 The red blood cells, composing the biggest iron pool in the body (280-390 µg iron) 
 The organs that exert storage function: liver, muscle, integument (10-100 µg iron) 
 The peripherical organs of the organism: kidneys, heart, brain, stomach (0.2-3 µg iron) 
 
 
Figure 3.6: The calculated pool sizes for the different organs under three diets. Data obtained from table 3.4. 
 
 
TABLE 3.4: The calculated pool sizes for the three dietary regimes. 
 
Compartment size Fe-Deficient Fe-Adequate Fe-Loaded 
Red blood cells 380 284 390 
    
Integument 42.2 39.2 36.4 
Liver 10.4 28.4 99.1 
Bone marrow 6.3 16.3 24.7 
Muscles 35.5 14.5 35.1 
    
Intestinal tract 3.7 3.8 8.4 
Kidneys 2.4 3.3 13.6 
Spleen 1.0 2.6 7.1 
Heart 2.2 2.6 4.3 
Lungs 2.2 2.4 14.3 
Brain 1.6 0.8 1.5 
Testicles 0.9 0.9 1.3 
Fat 0.5 0.5 1.3 









3.1.4 Hierarchy of Iron Residence Times in Different Organs 
 
To understand how the organs deal with the injected iron molecules – whether they store it 
for biochemical processes of return it to plasma – is necessary to asses the time scale of the 
system. In addition, this provides a realistic idea about the stiffness of the system that is 
being modeled. 
Using the fractional clearance rates from table 3.2 we can calculate the residence time of 
radioiron molecules in different compartments by equation (4), see methods. Table 3.5 
shows that there is a rapid circulation between the plasma, bone marrow and spleen 
(characteristic time below 1 day), intestinal tract (~2-3 days), an average circulation time in 
liver, fat, muscles and other inner organs (~5-13 days) and a longer residence time in red 
cells, brain and integument (greater than 16 days). 
 
 
Table 3.5: The calculated residence time that iron molecules spend in the organs of mice held under different 
diets. 
 




TF-bound* 0.05 0.05 0.05 1.2 1.2 1.2 
Spleen 0.07 0.14 0.52 1.6 3.3 12.6 
Bone marrow 0.4 0.9 1.8 9.9 20.5 43.7 
       
Intestinal tract 4.2 2.8 3.9    
Stomach 5.7 2.7 3.5    
Lungs 2.4 5.2 11.6    
Kidneys 5.0 5.0 4.3    
Muscles 32.1 6.5 7.1    
Liver 4.0 7.3 9.6    
Fat 10.3 7.9 10.1    
Testicles 20.5 10.8 15.0    
Heart 16.8 13.0 6.1    
Red blood cells 32.6 16.4 31.4    
Brain 49.7 16.4 35.7    
Integument 35.4 22.8 14.0    
 
 
It is also possible to see from table 3.5 that there is a hierarchy of time scales in the system. 
The following five groups of time periods are in accordance with literature data [23, 24, 33] 
and can be described as: 
 Rapid mixing of radioiron with transferrin pool/ECF: below 1 hour 
 Initial clearance of iron due absorption by the bone marrow, liver and muscle: ~1 hour 
 Reflux of tracer from the organs to plasma: ~2 days for intestinal tract and ~8 days for 
parenchymal organs. 
 Incorporation into iron storage or carrying proteins (red cells, muscles, integument and 
fat): ~1 month. 
 Complete excretion of the tracer from the body: ~200 days. 
 
It should be noted that the last aspect, the iron excretion, differs from humans. Miceloose 
around 0.5 % per day of their iron [23, 24], while humans loose less (only about 0.1% 
[24,58,72,73]). A characteristic time of 200 days means a considerable part of murine 
life-expectancy. So the mouse has an iron depot for its whole life, by contrast to humans.  
Another fact that can be observed for a number of organs is that for the most part of organs, 
the time-hierarchy does not change significantly between the three dietary regimes, also in 
accordance with the conclusion of [33]. However, exceptions are bone marrow, liver, spleen 




and muscles, where the different diets have an impact on the residence time of iron 
molecules in the organs. 
It is also noteworthy from table 3.5 and table 3.4 that there seems to be two kinetically 
distinct iron pools in mice: one which comprises about 20% of total body iron and has a 
residence time between 5 and 25 days and the second which comprises the other ~80% 
and has a residence time of ~200 days. The first pool type resides in liver, integument, fat 




3.1.5 Comparison of Tracer-accessible pools with unlabelled non-heme 
 
It is useful to understand how well the newly injected tracer iron mixes with the pre-existing 
iron in tissues. This gives an idea about how the organ's storage and absorption capacity 
changes under different dietary regimes. It is assumed that the tracer-accessible pool is a 
fraction of the total non-heme pool of the organs. To identify the pools that become quickly 
labelled we rely on the dynamics revealed by the tracer molecules. Table 3.6 provides the 
amount of non-heme iron for some organs under the different diets in this study. 
Table 3.6 shows that the amount of non-heme iron increases from 106 to 1600 µg iron (~ 15 
fold-changes) in liver of iron-loaded and -adequate diets. On the other hand, under 
iron-deficiency the pool is reduced to about half of normal non-heme levels (from 106 to 59.5 
µg iron). 
A dramatic change also happens in spleen, which under iron-loaded diet accumulates more 
than 120 µg iron (compared to 17.8 µg and 9.9 µg for iron-adequate and -deficient mice - ~ 7 
and 12 fold-change, respectively). 
 
 
Table 3.6: Non-heme iron content of mouse (C57B6/L) organs in different dietary regimes. Frazer et al. [70] give 
56 μg/g wwt. Vácha et al. [71] report 257 μg/g wwt. he concentration (μg non-heme iron per g of organ) data are 
unpublished data (K.Schümann for liver, kidneys, spleen and heart) and Vujic-Spasic & Muckenthaler for 
duodenum, lung, brain and muscle. The whole organ data were calculated as concentration times organ mass. 
The standard deviation was estimated from that of both sets of measurements (see methods). Note that liver, 
kidney and spleen store iron (ferritin) with increasing supply, whereas heart does not.  
 
Diet Fe-Deficient Fe-Deficient Fe-Adequate Fe-Adequate Fe-Loaded Fe-Loaded 
 Content Whole organ Content Whole organ Content Whole organ 
Organ μg/g wwt μg μg/ g wwt μg μg/g wwt μg 
Liver* 48.8 ± 5.1 59.5 ± 7.9 86.7 ± 14.9 106 ± 20 1310 ± 90 1600 ± 170 
Kidneys 36.9 ± 2.3 14.0 ± 2.0 60.8 ± 2.4 23.1 ± 3.2 88.1 ± 7.1 33.5 ± 5.2 
Spleen  141 ± 46 9.9 ± 3.5 254 ± 99 17.8 ± 7.4 1760 ± 240 123 ± 24 
Heart  71.2 ± 2.4 10.0 ± 1.5 68.2 ± 7.9 9.5 ± 1.8 81.8 ± 10.5 11.5 ± 2.2 
Duodenum    2.9 ± 0.3   
Lung    9.5 ± 0.8   
Brain    13.4 ± 1.7   
Muscle    142 ± 29   
 
 
In kidneys there is a decrease of 10 µg iron (~2 fold-change) between non-heme iron in 
iron-adequate and -deficient mice; and an increase of ~105 µg iron (~7 fold-change) 
between iron-adequate and -loaded conditions). 
Table 3.7 shows how the tracer-accessible pools relate to non-heme iron pools under the 
three different diets. The calculation used the values of table 3.4, which contain the 
estimated tracer-accessible pool sizes. 




We can see that the percentage of the liver compartment accessible to the tracer drops from 
27 to 6% when comparing iron-adequate with -loaded condition. The spleen also undergoes 
a reduction from 15 to 6%. 
Furthermore, comparing iron-adequate and -loaded conditions, we can see that the kidneys 
the heart has an increase in the percentage of compartment size occupied by tracer: from 
14 to 41% and from 27 to 27% for kidneys and heart, respectively. 
Analyzing the difference between iron-adequate and -deficient conditions, we can verify that 
the percentage occupied by tracer-accessible pools in some organs decrease (liver: 10%, 
spleen: 5%, heart: 5%) and in kidneys an increase of 3%. 
 
 
Table 3.7: Tracer-accessible Iron Pools compared with non-heme Iron in different dietary Regimes. The 
tracer-accessible pool sizes were calculated as described in the text. For the “cold” non-heme iron content refer 
to table 3.6. It may be noted that upon iron loading non-heme iron in liver and spleen is less accessible to tracer 
uptake, whereas in kidneys and heart the tracer-reachable fraction increases.  
 










Organ μg per mouse  μg per mouse  
μg per 
mouse  
Liver 10.4 17 28.4 27 99.1 6 
Kidneys 2.4 17 3.3 14 13.6 41 
Spleen 1.0 10 2.6 15 7.1 
 
6 
Heart 2.2 22 2.6 27 4.3 37 
 
 
3.1.6 Iron Excretion from the body 
 
Iron, as mentioned before, enters the body by the duodenum and to a lesser extent from 
other parts of the small intestine. Iron is lost from the body via mucosal exfoliation, skin 
desquamation and also via bile und urine [72]. The iron lost by mice is about 2-5 times 
greater than in other animals and man [24, 34, 58, 72-74]. Therefore, it may be hard to 
develop an iron-overload scenario in mice without a severe mutation. 
Table 3.3 shows that the losses through skin and intestine desquamation appear to be in the 
same range. The amount of iron leaving the body through skin desquamation in 
iron-deficient, adequate and loaded mice are respectively 1.19; 1.71 and 2.6 µg iron per day. 
The iron losses due intestinal mucosal exfoliation (intestine + stomach) are 1.22; 1.5; 2.3 µg 
iron per day for iron-deficient, -adequate and -loaded, respectively. 
 
 
3.2 Simulation Studies with the Cellular Model 
 
The kinetic model of iron metabolism that we have sketched in the methodical section needs 
the assignment of suitable values for the numerous parameters. We achieved this by 
applying the pool sizes and flux rates as calculated from tracer data in the previous section. 
The source of these estimated parameters are the tracer data of Schümann et al. (2007) 
[27], complemented by quantitative statements obtained from the physiological literature on 
iron metabolism. The flux values and pool sizes are stated in fig. 3.5 and 3.6. They define 
the quantitative range of the major fluxes in all cell types and tissues and set therefore 
parameters for input, throughput and output of iron, together with the equilibration of ferritin 
stores and heme synthesis. Other internal events are of minor quantitative importance, and 
it is therefore possible to set the parameters in a dimensionless form derived from the 
reference state of an adult, healthy and well-fed (also in terms of iron supply) mouse.  
 




In this part we report findings of simulations performed for several physiological and 
pathological conditions: i) to see the effect of considerable blood losses by bleeding, ii) to 
assess the cellular and physiological changes to the organism under iron deficient or loaded 
diet, iii) to study the role played by hepcidin and IRP system in iron regulation. All results are 
obtained as parameter portraits (section 2.22). We present extracts here as percentage 
changes of certain salient parameter jumps.  
 
 
3.2.1 Simulation of Chronic Blood Loss 
 
In our simulations we established a daily blood loss with different degrees of severity. In 
model terms, a leakage of iron was introduced in the RBC pool. Instead of a complete route 
of RBC to the RES compartment, there is then a parameter characterizing loss of blood iron 





The constant loss of red blood cells has a strong effect on the erythropoietic mechanism of 
the body (fig. 3.7). The change in the daily blood loss by 1% of the formation rate causes a 
parallel decrease of serum iron (transferrin saturation) by a factor of 40%. The consequence 
of lower transferrin saturation levels is that less iron is circulating and available for heme 
synthesis in the bone marrow. In this organ, the flux v1 (iron uptake by transferrin receptor 1, 
TFR1, also shares a parallel decrease and for each percent increased of the daily blood loss 
v1 level is reduced by 14%. 
It can also be observed that the heme export (w10) is reduced in parallel under chronic 
blood loss: 1% increase in the daily loss of iron reduces the export of heme by 12%. It can 
be observed in the figure 3.7 that the level of RBC is also reduced in parallel and with 1% 
blood loss per day, it causes a reduction of 23% in the final level of RBC, where a new 
steady state is reached. 
The reserve of iron in the bone marrow (Phi1 and Lambda) is also reduced under constant 
blood loss: 1% increase of the daily loss of iron reduces the levels of ferritin and free iron by 
12 and 10% respectively. 
The presence of the main receptor of iron in the bone marrow (TFR1) is increased when 
there is a chronic blood loss. For each percent of iron lost in red blood cells, the expression 
of this receptor increases by 16%. This happens due the stimulatory effect exerted by 
Erythropoietin (EPO). This hormone is produced at high levels in hypoxia situations, and in 
our model for each percent of blood lost on a daily basis, there is an increase of 40% in the 
level of EPO. And due to this increase, the production of TFR1 is also elevated. This is 
interpretable as a feedback loop in order to bind and internalize as much circulating serum 
iron as possible. 
  






Figure 3.7: Blood loss and its relation to body iron status indicators. RBC, hepcidin and transferrin saturation 
fall in parallel with increases in the daily percentage of red cell loss. On the other hand, EPO increases almost 
linearly, due the demand for new erythrocytes and the duodenal iron absorption also increases until it reaches a 
plateau after 1.8% daily loss. 
 
 
3.2.3 Recycling of iron 
 
Under normal conditions, the major source of iron for the blood plasma is the Reticulo 
Endothelial System (RES). The iron released from the macrophages consists of molecules 
that were recycled from senescent red blood cells and ineffective erythropoiesis. In a 
chronic blood loss scenario, there is a constant decay in the level of the major source of iron 
molecules (RBC) that would be recycled and released into circulation. 
In our simulations we observed that the v7 flux into RES (sum of iron intake from the two 
above mentioned sources) decreases in parallel with the constant blood loss: 25% less flux 
for each percent of blood lost daily. Since the system is in a steady-state, even with the 
constant blood loss, the same happens with the flux w6, which is the export of iron into 
circulation.  
The iron stores in the macrophages also suffer a decrease (not shown as parameter portrait), 
For each percent of iron lost daily, the levels of Phi1 (ferritin bound iron) and Lambda (Labile 





The iron uptake, storage and the eventual export from the liver decreases with blood loss. It 
can be observed from our simulations that 1% increase in the daily loss of red blood cells 
implies almost 20% lesser iron uptake by TFR1(v1 flux). As in the bone marrow, in the liver 
the expression of TFR1 is also increased . However, this increase in liver cells is much less 
pronounced than in bone marrow. In the liver the expression of this receptor in the cell 
membrane increases by around 1% for 1% daily blood loss. 
The iron stored in ferritin form (Phi 1) and the cellular labile iron pool (Lambda) are reduced 
aby bout 18% for each percentual increase in the daily blood loss.  
The iron export from the liver cells through ferroportin is also reduced by 20% for one 




percent loss of red cells. It was also observed that the level of ferroportin loaded with iron 
molecules (Fpn1) is reduced; even on simultaneous decrease in the expression of hepcidin, 
which is known to reduce the expression of ferroportin. 
A parallel reduction can also be observed in muscle cells. Ferritin iron (Phi 1) and the labile 
iron pool (LIP) are reduced by 20% for each percentual increase in the daily blood loss. In 
addition, the absorption through Transferrin receptor 1 (v1) and export through ferroportin 




Figure 3.8: The reserves of iron are linearly depleted with increases in the daily loss of iron. Both forms, ferritin 





The absorption of dietary iron in the duodenum is mediated through DMT1 (m0 and m1 
variables in our model). Its flux, termed v5 as panel in fig. 3.7, increases with a 
saturation-like curve witzh the daily loss of red cells, reaching a plateau after 1.8% daily 
blood loss. With 1% daily blood loss, v5 increases 68% and its plateau is achieved after 80% 
increase in the dietary absorption. 
Due this high increase in dietary iron absorption, the iron stores in ferritin form (Phi1) and 
the labile iron pool (Lambda) also increase correspondingly with increases in blood loss. For 
a 1% increase in blood loss, we observe an increase of 50% in Phi1 and Lambda. However, 
they also reach a plateau after about 1.8% daily blood losses. 
The iron export to the plasma is also increased in this blood loss scenario. It was observed 





The excretion of iron from the body happens through 2 distinct mechanisms: by loss of 
intestinal mucosa cells and by skin desquamation (integument). 
From our simulations we observed that with increases in the daily loss of red blood cells 
(and consequently less iron circulating in the body), the excretion of iron is diminished. This 
decrease in iron excretion can be observed in equal proportions both in intestine and in the 
integument. For a percentual increase in blood loss, the flow of iron from the body to outside 
(flux w13) is reduced by about 20%. 
In addition, it can be observed that the iron stores in the intestine and in the skin are also 
reduced. Both ferritin iron (Phi 1) and the labile iron pool (Lambda) decrease by more than 
20% for each percent of daily loss of red cells. 
 
 
3.2.7 The new steady state 
 
The new steady state in our simulations, after a slow ultimate drift, would be reached after 
many days from the beginning of the daily blood loss. 


































29 days. With a greater daily loss (2%), the half-time necessary to achieve the steady state 
would be around 89 days (figure 3.9). This new steady state has different levels of red cells, 


























Figure 3.9: Time necessary for the model to establish a new steady state with a daily loss of iron. As was 
demonstrated in the previous sections, the dietary uptake to compensate for this new daily loss is increased but 
does not overcome totally the demand for new red cells. Therefore, a new state exists were there is less 
circulating red cells than the reference levels. 
 
 




With changes to parameter K5 of our model, the flux v5 (absorption of dietary iron via DMT1) 
is either increased or decreased. It can be observed that the value of v5 increases 
exponentially with changes in K5. Increasing or decreasing the value of K5 by 50% causes a 
change of 20% (figure 3.10). 
The iron stores in the cell, either in ferritin form (Phi 1) or in the labile iron pool (LIP) are also 
increased or decreased according to the amount of dietary iron absorbed by the intestinal 
cells. Doubling or reducing the amount of available dietary iron causes an increase by 12% 
of Lambda and Phi 1.  
The export of iron from intestinal cells is also increased or decreased by 20% respectively 
for higher or lower values of K5. 
While the stores and the iron export from the cells increase with greater values of K5, the 
opposite happens with the amount of active IRP in the cell (Yeff, representing a sum of IRP1 
and IRP2). It can be observed that with lower dietary iron supply, the amount of Yeff is more 
than linearly increased. This happens because with less iron available in the intestinal cells 
two processes related to IRP are reduced: first, the conversion of IRP1 from its active form 
into cytosolic aconitase and second, the degradation of IRP2, which happen with iron levels 
above a certain limit (figure 3.10). 
 






Figure 3.10: Relation of changes in the dietary iron supply (flux v5, controlles by parameter K5) and iron 
fluxes/storage/regulation. With increased iron supply, the levels of ferritin iron and iron export through 
ferroportin are increased. Meanwhile, the activity of the IRP system decreases due degradation of IRP2 and 





The increased transfer of iron from the duodenum into the circulation is accompanied by 
greater transferrin saturation. The opposite also holds, decrease in dietary iron supply leads 
to lower transferrin saturation. In quantitative terms, in both directions, either increasing or 
reducing the dietary availability of iron by 50% changes the ratio tao1 / (tao1 + tao0) by 12% 
(Figure 3.11). 
It was observed that with decreased iron supply from the diet there is a rise in the EPO 
levels. This increase results in more TFR1being expressed in the bone marrow. However, 
even with increased levels of this receptor, the supply of transferrin iron from the circulation 
is decreased, since the level of transferrin iron is reduced under lower dietary iron supply. 
The storage of iron in its ferritin form and in the labile iron pool is also reduced in bone 
marrow in the case of lower dietary iron supply. This decrease is not drastic, since the 
reserve of iron in the bone marrow is relatively small by comparison with other organs like 
liver or spleen (figure 3.11). 
Ultimately, the production of heme in the bone marrow is increased or decreased in the case 
of higher or lower dietary iron supply, respectively. The change leads to higher production of 
red blood cells, which are increased or reduced in 10% for 50% more or less dietary supply, 
respectively (figure 3.11). This tendency would be damped by a higher cooperativity 



























































   
 
Figure 3.11: With increases in duodenal iron supply, there is an increase in the iron absorption in the bone 
marrow through TfR1, its ferritin stores also increases and consequently the RBC levels are also increased. 
However, the expression level of TfR1 (alpha) at the cell membrane is diminished due the decrease in the EPO 
levels. In addition, the transferrin saturation is also increased, providing more iron to every organ in the model 





With increased or decreased iron supply by the diet, the absorption of iron by the RES 
macrophages is also either increased or decreased. The flux v7, which represents the sum 
of RES iron uptake from senescent red cells and from bone marrow, due toineffective 
erythropoiesis follows the same trend as the flux v5 from duodenum (figures 3.10 and 3.12). 
In addition, the stores in the RES are also reduced in case of lower iron supply in the diet. 
This reduction in both forms of cellular iron (ferritin and labile iron pool) is very strong: 
changing the iron supply by 50% causes changes in Phi 1 and Lambda by 66 and 40% 
respectively. 
It can also be observed that the release of iron from RES is also decreased in case of 
reduced iron supply by the diet. However, for a change of 50% in the dietary supply, there is 
a change of just 10% in the level of iron export from the RES. 
 






Figure 3.12: With increased duodenal absorption there is an increase in the iron supply in the RES, due 
ineffective erythropoiesis. It can also be observed that the ferritin level in the RES system is also increased. The 
same happens with the export of iron to blood plasma, it follows the same trend as the two other previous 





In a scenario of reduced iron supply from the diet, the body stores present mainly in the liver 
will also be depleted. Both forms of iron, in its ferritin form and also as labile iron pool are 
reduced according to the decrease in iron supply in the intestinal cells. Changing the dietary 
iron supply in 50% causes a change in lambda and Phi 1 by 10 and 14% respectively. 
In addition, the export of iron from liver cells is also reduced in the case of lower duodenal 





Figure 3.13: The reserved in the liver and muscles are increased with higher duodenal iron absorption. Iron in its 
two forms present in our model, ferritin and the labile iron pool have higher values after changes to the duodenal 





Iron losses from the body are also reduced or increased according to the amount of iron 
absorbed from the diet. In organs like the intestine or the skin (integument), the iron stores in 
ferritin form or the labile iron pool are either increased or decreased, following the same 
trend of the flux v5 in the duodenum (figure 3.14). 












































































w13, is also increased or decreased on higher or lower dietary iron absorption. Changing by 
50% the amount of iron absorbed in the duodenum causes a change of 18 and 14% in the 




Figure 3.14: With increased iron levels in the body, the excretion level through skin desquamation and mucosal 
exfoliation are also raised. Note that the reference level of the model is at K5=5. 
 
 
3.4 Hepcidin Studies 
 
3.4.1 Hepcidin seems not to be active in Liver Hepatocytes 
 
Ramey and collaborators [75], have published experiments. where hepcidin targeted 
ferroportin for degradation in liver hepatocytes. If this would be operative in our model, then 
a hepcidin knock-down should lead to higher expression of liver ferroportin and 
consequently to lower iron levels in this organ. This would not explain , however, the 
observed in crease [76-78] of iron in hepcidin hemochromatosis. The paper [79], on the 
other hand, suggests that the hepcidin effect is different dependent on the target organ. In 
our model it can be shown (fig. 3.15) that with hepcidin acting in liver hepatocytes, there is 
no increase in stored liver iron, compared with the implementation where hepcidin acts only 





Figure 3.15: Comparison of different model configurations. If hepcidin also targeted ferroportin in hepatocytes 
for degradation, there would be not enough iron accumulation to characterize the iron overload reported in 
several studies [76-78]. Note that the reference (normal) level of hepcidin expression is at U8=0.3. 
 
 
3.4.2 DMT1 and ferroportin expression changes 
 
As demonstrated in two different studies [53, 79], the increase in hepcidin levels leads to a 
decrease in the expression level of DMT1. It can be observed that with increased levels of 
hepcidin, the level of DMT1 is reduced by about 10% and with steps toward a hepcidin 
knock-out mouse there is an increase in the level of DMT1 by up to 50% of its original value 
(figure 3.16). 







































































hepcidin in the organism [53]. “Level of hepcidin” in the organism is ambiguous, when 
related to blood or urine measurements [80, 81]. It probably refers to the total production in a 
given time period, and therefore a measure of the turnover rate. Changing the expression 
levels of hepcidin in our model we obtained the same as their study: reducing hepcidin we 
observe an increase in the expression level of ferroportin (figure 3.16). This increase in iron 
transported was also confirmed experimentally by [77]. 
Reducing the level of hepcidin we observe an increase in the expression of ferroportin, 






Figure 3.16: the increase and decrease in hepcidin expression is inversely followed by expression levels of 
DMT1 and ferroportin in duodenum. Near an absolute lack of hepcidin there is an exponential increase in the 
expression of those two proteins. Note that the normal level of hepcidin expression is at U8=0.3. 
 
 
3.4.3 Iron in Spleen 
 
According to [78] and [77] in case of lack of hepcidin it can be observed that the iron level in 
the spleen is decreased. In our simulations we could observe the same effect (figure 3.17), 
decreasing the hepcidin levels there is a correlated decrease in the ferritin iron stores in 
spleen (Phi1). 
This decrease in the iron stores in the RES can be explained by the increase in ferroportin 
levels and consequently the efflux of iron from the spleen macrophages. This was also 
confirmed experimentally by [78] and [77] and can be seen in (figure 3.17). However, these 
results are in conflict with the findings of [76] who observed no changes in the RES iron 





Figure 3.17: with lack of hepcidin there is an increase in the levels of the membrane iron transporter ferroportin. 
Consequently the ferritin iron stores in the RES are decreased. Note that the normal level of hepcidin expression 

































































3.4.4 Transferrin Saturation and Erythropoiesis 
 
It was reported [78]) [76] that the transferrin level of mice lacking hepcidin expression is 
increased. This could be observed in our simulations where the level of transferrin saturation 
(Tao1 / ( Tao 0 + Tao 1) in our model) increased according to the reduction of hepcidin in the 
organism (figure 3.18). This is a characteristic of hemochromatosis and an indicator used to 
diagnose this disorder. 
However, those same studies reported that there were no changes in the level of RBC in 
mice lacking hepcidin expression. In our model that there is an increase in the level of RBC 
in mice lacking hepcidin. However, the increase is not very high until the level of hepcidin is 
extremely low, a most severe condition where other factors not included here may interfere. 
Therefore, from (figure 3.18) we may conclude that the problem could be solved in future 
versions of the models by adapting the cooperativity parameters of EPO signaling or 





Figure 3.18: at very low values of hepcidin expression we can observe an increase in the erythrocytes and in the 
transferrin saturation. These two events are related since with higher serum iron there is more uptake by the 
bone marrow, which produces an increased number of red cells. 
 
 
3.5 IRP Studies 
 
According to several studies [44, 82], IRP 2 dominates the intracellular iron homestasis in 
mammals. The mentioned studies performed IRP 1 and IRP 2 ablations and concluded that 
in most part of tissues IRP 2 expression can be increased in order to compensate the lack of 
IRP 1. However, the opposite is not true: in absence of IRP 2, IRP alone is not able to 
maintain alone the control of TfR1, DMT1 and ferritin levels [44]. 
This feature was implemented and tested in our model. In the reference state IRP1 exerted 
an effecte that was responsible for 5% of all IRP activity in the cells, while IRP 2 was 
responsible for the other 95%, in agreement with [56]. 
With those values we were able to simulate and observe most of the results reported in the 
literature. Below is a summary of our observations and comparison with the literature. 
 
 
3.5.1 Transferrin Saturation and Erythropoiesis 
 
The transferrin saturation in our model expressed by (Tao1 / ( Tao 0 + Tao 1)) was not 
changed when we changed the expression of IRP 1 or IRP 2 to either lower or higher values 
(figure 3.19). This observation is accordance with the studies of [83] and [42]. 
In addition the RBC levels are reduced when there is a decrease in IRP 2 expression (figure 
3.19). This observation was also reported by [83] but not by [42], who mentioned that there 













































Figure 3.19: with lack of IRP2 expression in tissues there is a decrease of RBC despite the fact that no change 





In the study of [83] it was observed that the level of ferritin heavy and light chains change 
when there is a lack of IRP 2 expression. But we do not differentiate in our model the two 
different isoforms of ferritin, we could observe that there is a decrease of this protein when 
we simulate an ablation of IRP 2 (figure 3.20). 
Two differences between our model and the experimental results published by [83] refer to 
the levels of DMT1 and ferroportin. In their paper, they report that in the IRP2-/- mice, the 
level of DMT1 and ferroportin is unchanged. However in our model we observed that the 
level of DMT1 is decreased with lower expression levels of IRP 2 (figure 3.20). This 
difference can be due the different isoforms of DMT1 (with or without IRE, alternative 
splicing. [84]). In addition, in a different study where a conditional knock-out targeting only 
the IRP system in the intestine was made [85], it was observed that DMT1 is decreased, in 
accordance with our simulaion.  
The same happens with ferroportin level, where [83] report that it is unchanged and in our 
simulation we found it to be decreased with lower IRP 2 levels (figure 3.20). 
These differences confirm the point of view of [44] who pointed out that there are important 
characteristics that are not totally understood regarding the role of IRP1 and IRP2 in 




Figure 3.20: with lack of IRP2 expression there is a decrease in ferroportin and DMT1, however, there is an 
increase in the level of ferritin iron which corresponds to the observations of [83]. Note that the normal level of 






























































































Simulating the ablation of IRP 2 gene in the whole organism we observed in our model an 
increase in the level of ferritin in the liver (figure 3.21). This observation is in accordance to 
the experimental studies of [83] and [44]. 
In the study of [83] it was also reported that the level of TfR1 in liver hepatocytes is reduced 
under lower expression of IRP2. This characteristic could be also observed in our model 
(figure 3.21). Since IRP2 exerts a protective role in the mRNA of TfR1, it is expected that 
there is a decrease in the protein level of this transporter. 
The hepcidin levels in our model and in the experimental model of [83] are also in 
accordance. In their work they reported that there is a slight increase in the expression level 
of hepcidin, but it was not high enough to be statistically significant. In our model we have 
the same: there is an increase but not enough to be considered important (figure 3.21). 
The only divergence between our model and the experimental work published by the 
above-mentioned authors refers to the ferroportin level. They report that there is no 
difference in the expression level of ferroportin in the liver of IRP2 ablated mice, while our 
theoretical simulations show that the level of ferroportin would be severely reduced under 
lower expression of IRP 2 (figure 3.21). Since the IRP system has a protective role over the 
mRNA of ferroportin it would be expected that the level of this protein would be reduced. 
This discrepancy sugggests the existence of a modified biological mechanism for the 
regulation of ferroportin in hepatocytes. This mechanism was not yet found. It may involve 




Figure 3.21: with lack of IRP2 expression there is a decrease in ferroportin and TfR1, since the IRP system 
provides protection of the mRNA of those genes against degradation. However, just the decrease of TfR1 is in 
accordance with [83]. There is an increase in the level of ferritin iron, in accordance to the experimental work of 
the same author. In addition, there is no change in the hepcidin level. Note that the normal level of IRP2 





There is some divergence between the observations in the spleen compartment of our 
model and the measurements on spleen reported by [83]. They reported that the level of 
ferritin iron in the spleen decreases under IRP 2 ablation. In our model the opposite effect 
obtained: the level of ferritin increased. In addition, the same authors report that the level of 




































































observed that the level of ferroportin is not changed with lower IRP 2 expression values 
(figure 3.22). 
The only agreement between our model and the experimental data concerns the iron 
acquisition by the spleen. In our model this originates as “ineffective erythropoiesis”. Galy 
and collaborators [83] report that this acquisition is reduced in IRP 2 ablated animals and the 
same observation was made in our simulations (figure 3.22). 
Again, these differences direct us to the conclusions of [44] who pointed out that there are 
characteristics that are not understood the IRP system in different organs. 
 
 
Figure 3.22: with lack of IRP2 expression there is a decrease in ferroportin and in the iron acquisition. It can also 
be observed an increase in the ferritin levels in the spleen macrophages which is not in accordance to the 
literature. Note that the normal level of IRP2 expression is at U2=1.0. 
 
 
3.5.5 Bone marrow 
 
In the studies of [83] and [42] there is one point of agreement and one of divergence. Both 
reported that in erythroid precursors the level of TfR1 is reduced in mice with IRP 2 ablation. 
This is also in accordance with our simulations and can be explained by the fact that the IRP 
system prevents the mRNA of TfR1 of getting degraded (figure 3.23). 
The observed fact that is different between the two papers deals with the level of ferritin 
protein: while [42] reports that the level of this protein increases, [83] observes that its level 
did not change with IRP 2 ablation. Our simulations are in accordance with [83], since we 




Figure 3.23: In IRP 2 knock-out mice there is no change in the level of ferritin iron in the bone marrow. However, 
there is a strong reduction in the level of TfR1. Both observations are in accordance to the study of [83]. Note 














































































3.6 IRP and Hemochromatosis 
 
In the study of [82] it was reported some interesting characteristic was reported between the 
interaction of the IRP system and the lack of hepcidin expression in patients suffering from 
hereditary hemochromatosis.  
The first is that in macrophages and monocytes of HH patients there is an increase in the 
level of IRP 1 and IRP 2. In our model the effect of both IRPs is summarized in the term Yeff. 
We can observe in (figure 3.24) that with lower expression of hepcidin there is an increase in 
the level of effective IRP in spleen macrophages, observation which is in agreement with the 
experiment. 
The second fact reported by [82] is that in the duodenum of both anemia and 
hemochromatosis patients there is an increase in the level of IRP activity. In our simulations 
we could also observe the same effect. Reducing the expression of hepcidin or reducing the 
intake of iron from the diets caused the pathological effects and could explaion the values of 





Figure 3.24: In the duodenum of hereditary hemochromatosis or anemic patients there is increased activity of 
IRP activity. The same happens in the macrophages of patients with hemochromatosis. Please note that the 
















































4 - Discussion 
 
4.1 Mathematical Model of Iron Metabolism – General Structure 
 
The vital importance of iron for redox catalysis and oxygen handling and its strong toxic 
potential of its radical-forming capacity require a very carefully fine-tuned regulation of 
absorption, excretion and inter-tissue distribution as well as of cellular balance and 
intracellular deployment for biosynthesis and storage. A systems biological approach to 
understanding this complexity requires the application of a mathematical model which 
integrates the molecular and cell-biological detail in a way that makes the regulatory 
structure transparent. Ingenious interpreting work has so far been done on a qualitative level, 
but a full quantitative description of the cellular and organismal hierarchy is still missing. In 
the work presented here a first such model is presented for the iron metabolism of the 
mouse strain C57BL6. This is the most widespread and best characterized model animal for 
studying organismal status and transgenically constructed pathology of iron metabolism. 
 
From a technical point of view the model presented here follows a standard methodology of 
systems biology. We envisage the organism as an aggregate of organs and tissues, each of 
which represented as an idealized compartment, consisting of a given number (or volume) 
of cells. Transport into and out of a compartment and the interconversion of its elements is 
described as a network of metabolites and reactions, characterized by well-defined 
biochemical and biophysical status and interconversion descriptors. Metabolites are 
quantified by content (or “concentration”), and the dynamics of transfer of “substrate” into 
“product” is quantified by a reaction rate. The reaction rate is a function of the content in 
partaking metabolites and contains parameters of the catalysts and the signals (inhibitory or 
activatory) that influence the interconversion. The whole system´s dynamics is then 
described by a balance sheet of differential equations which usually are linear combinations 
of the reaction rates according to the stoichiometric matrix of the system. 
 
This theory has envisaged metabolic systems as a kind of “well-stirred” biochemical reactor. 
It has been applied to holistic descriptions of E. coli, yeast cells and erythrocytes [86] [87-89]. 
For more complex eukaryotic cells the basic tenets of the theory, especially compartment 
and reactant homogeneity, are not given, and the description has to introduce 
subcompartments or has to integrate over the whole cell. In a cell with multiple subspaces 
embedded in a membranous structure filled with organelles and a certain content in 
macromolecules the description is bound to become phenomenological, assuming that a 
system can be quantitatively described in the conceptual framework of a cellular reactor, 
where the compartments, the variables and the parameter definitions and their numerical 
values are valid as a weighted average over the object considered.  
 
Iron metabolism has some special properties that render such an idealized description 
applicable, and it has other features which introduce specific restrictions. The typical iron 
content of a cell, when expressed as if it were a homogenous water solution, is in the 
millimolar range (for instance 120 mg non-heme iron per kg liver, or, for that matter, 3 mg 
iron for 50 l water of a 70 kg human body [90]), but the cytosolic “concentration” of LIP (labile 
or transit iron pool) is in the micromolar range at most [26]. The bulk of iron is bound to 
specific protein carriers (below the micromolecular range), most of them containing per 
molecule only one or a few iron molecules (such as transferrin or myoglobin). Only ferritin 
and hemosiderin are able to corral up to 4500 iron atoms per macromolecule fold. It is 
evident that a kinetic description in classical terms does not apply in such situations, and 
only a phenomenological “quasi”-description is possible that has to justify itself by the 
criterion of “producing the global phenomena”.  





However, there are features that greatly simplify an adequate systemic description. One 
point in case is that fact that iron is inorganic and therefore alien in the ocean of bioorganic 
matter. So only few specific proteins or translocators of iron (and other metals) need to be 
considered. A second point is that iron is as Fe (II) or Fe(III) always in electrostatic 
coordination rather than in covalent bond, so the number of kinetically relevant biochemical 
states, although as prosthetic group present in multifarious protein entities (more than 100 
species coded for in the whole genome [91], is limited in terms of metabolic turnover. Most 
of the states of iron bound to specific proteins are now well known and easily traceable by 
physical measurement. A further point is the residence time of most iron atoms in active 
cells is longer than the life-time of the carrier molecules (e.g. about 7 days vs. 1 day in liver), 
so one can assume that the binding/releasing cycle as well as the renewal of protein carriers 
is close to steady-state. 
 
 
4.2 Structural and Kinetic Hierarchy of the Model 
 
The structure of the model is a set of peripheral organ and tissue compartments connected 
via a central compartment. The relative organ weight is the factor that integrates the 
compartments to a whole system. Each cell type is contains three levels of intertwined 
kinetic representation: material transfer of iron, synthesis and decay of the protein arsenal, 
and the regulatory superstructure (mainly IRP/IRE system). On the organismal scale there is 
the exchange flux into and out of the central compartment and the global absorption (via 
duodenum) and loss of iron (several organs), the turnover of the transferrin carrier and the 
regulatory superstructure (hepcidin for the iron household, and erythropoietin for the 
erythron). Hepcidin as a hormone has a similar function for global homeostasis of iron as 
has insulin for carbohydrate homeostasis. Both act as a feedback signal produced by a 
sensor cell reporting a high level (hepatocyte and pancreas ß-cell, respectively), and both 
exert their main effect via a membrane receptor in certain cell types (ferroportin vs. insulin 
receptor).  
 
Compartment content and within- and inter-compartment transfers and fluxes are the main 
kinetic elements of the system. Simple linear kinetics has been installed for the turnover of 
the protein arsenal. The elementary kinetic formalism for material iron transfer is a rate law 
bilinear in iron content and in protein acceptor level for iron binding and a linear rate of iron 
release. Where regulatory signals have been experimentally demonstrated to be operative 
the basic rate law is multiplied by a simple signal expression (power law). Since the 
hormonal signals are triggered and exert their effect with a considerable gain we chose the 
exponent of the power law greater than unity. For the cellular IRP/IRE a value of unity was 
sufficient, since the experimental background was only qualitative. Anyway, the effect of a 
high exponent in a steady-state system is mainly the swiftness of concentration jump in 
order to trigger an effect. As is well known, high non-linearity introduced by steep signals in 
metabolic systems may produce alternative states or oscillations, but our system has only 
one potential positive feedback loop (i.e. back effect of hepcidin on the liver), but there is no 
indication so far that the system may run over a bifurcation surface (i.e. over a structure in 
the parameter space where the qualitative behaviour makes a sudden jump). 
 
The quantitative domain in which each cell metabolism is operating is set by the 
experimentally measurable content of the major iron fraction as well as the distribution of 
radioactive tracer into the organs and back into the central compartment. For the 
non-transferrin part of iron transport (haptoglobin- and haemopexin-borne) there were not 
enough quantitative data available, and it had to be modelled therefore only cursorily. The 
intracellular steady-state structure of most iron-related pathways, due to the nanomolar 
content level of the individual iron-carrying proteins, made it possible to apply the integrative 




assumptions, i.e. aggregation of kinetically similar reactions into one component (e.g. 
haemo- and myoglobin synthesis, mitochondrial iron uptake, iron-sulfur biogenesis), and 
normalization of contents and fluxes to a common reference state (adult healthy mouse on 
adequate iron food). Any further specification of the model must await corresponding 
quantitative determination as experimental input. 
 
What can be expected and what cannot be achieved with a kinetic model as presented 
here? 
The answer is:  
 a quantitative representation of the iron status, globally as well as for specific cell 
types,  
 a quantitative representation of the major iron fluxes into and out of the major 
tissues,  
 a qualitative evaluation of the regulatory structure within and between cell types, in 
particular the interaction of local and global feedback signals,  
 and certain global switches (e.g. between iron supply for the erythron and into the 
parenchymal iron stores.  
This can be done for the reference state of the normal mouse, but also for certain 
perturbational variations:  
 different iron supply,  
 acute and chronic blood loss, application of chelating therapy)  
 structural changes (e.g. brought about by genetic mutation, spontaneous or 
experimentally constructed).  
This can be studied either by variation of the boundary conditions (e.g. acute loss from the 
RBC compartment) or of the parameter structure of the model. Parameters may be varied as 
a jump (as if by a gene knock-out) or by continuous variation that makes it possible to adapt 
the model structure to realistic measurements. The parameters of the models belong to 
three classes:  
 of kinetic property (e.g. to simulate a mutation in an iron-carrier or transporter),  
 of gene expression (e.g. to simulate a knock-out or knock-in), and  
 of regulatory power (e.g. to simulate interference into a signalling chain).  
In what follows we discuss the results that we have obtained for establishing parameters 
from flux and content measurements in vivo, of physiological inferences that can be made 
from such estimates, and of computer experiments of acute and chronic changes of the 
model structure compared with explorative simple simulations. 
 
 
4.3 Model Parameterization from Experimental Data: Iron Status and 
Fluxes 
 
From the viewpoint of systems analysis, iron metabolism of the body is an open black-box 
with input, internal processing and output. Absorption fluxes and losses are relatively slow 
compared to internal iron circulation [90, 92]. The most relevant internal dynamic events 
occur within the first few days after tracer injection. They involve the plasma iron turnover 
and the turnover of the erythron. On this time scale the system is nearly closed, with input 
(absorption) and output (excretion, desquamation) being slow compared to the dominant 
rates of inner metabolism. Iron absorption from guts is in the range of 0.5 µg per day 
(calculated to whole-body scale from the data of Bahram et al. [93] and Lebeau et al. [35], 
whereas the rate of total plasma iron exchange with the body periphery, as shown in table 
3.2, is in the range 20 – 30 µg per day. Such a system will approach an inner steady-state 
with slowly drifting concentrations and fluxes. 
 
 




To study such a steady-state one can measure stationary content variables and inject a tiny 
dose of Fe59, preferentially bound to its transferrin carrier [94], into the central compartment 
of radioactive iron. In the initial hours after mixing of the injected iron, when the periphery 
does not appreciably return tracer, the flow of blood into the organs is proportional to the 
flow of tracer. This initiates distribution dynamics of the tracer in conformity with the pools 
and stationary rates of the unlabelled bulk of iron in the steady-state, which is not disturbed 
by the addition of trace amounts. The time course of the ensuing run-off of tracer distribution 
obeys a system of ordinary differential equations with constant coefficients.  
 
 
4.4 Iron status of the adult mice on different dietary regimes 
 
The experimental data which form the basis for the model calculations presented here are 
derived in adult mice that were on different dietary regimes during growth. The adult animal 
develops a steady-state which is maintained during its further adult life, i.e. for approximately 
1-2 years. This assumption is prerequisite for the ferrokinetic model. The empirical 
background for the model consists of the static iron status and of tracer dynamic data. 
 
 
4.5 Modelling iron fluxes by the Fe59 tracer method 
 
The literature contains numerous papers (e.g.[6, 7, 10-12]) which measured the dynamics of 
iron metabolism on the intact organism with the help of the tracer Fe59. The basic rationale is 
that the tracer, while being always measurable as radioactivity, due to its tiny relative amount 
does not perturb appreciably the iron status of the body. Most of the mathematical models 
derived from such measurements were obtained for humans, dogs and rats. Only the paper 
by Vácha et al. [13] derived a whole-body model for the normal mouse , collected from 
measurements in blood, liver and spleen, without systematic control of dietary regime. The 
model was based on a number of ad-hoc assumptions of fluxes, which partly could not be 
substantiated by cellular mechanisms, and the parameters were in part estimated without a 
whole-model statistical fitting procedure (computer capacity-limited). We can confirm, with 
the experimental evidence now available, that their ingenious model, in spite of some 
speculative elements due to limited molecular knowledge, gives a remarkably adequate 
description of the global dynamic structure of murine iron metabolism 
 
 
4.6 Iron status 
 
This is defined as the iron content of the iron fractions in the different organs and tissues. It 
reflects the expression of protein carriers to which iron is bound (transferrin, ferritin, heme 




4.7 Dynamic fluxes 
 
The second data type is the time course of iron flow through body organs after 
administration of a radioactive tracer. The data base stems from partly published 
measurements of Prof. Schümann´s lab [27] and from studies done elsewhere under a 
comparable experimental design. The aim is to integrate the entire data set into an 
integrative model, thereby displaying the systemic structure which is not obvious from 
inspection of raw data.  
 




4.8 Kinematic model of iron flux steady-state 
 
The crucial supposition for a representative model is that iron fluxes in the body are 
(approximately) balanced and cellular pools do not fluctuate violently during the 
experimental period. Tracer injection permits to collect data on internal fluxes without 
upsetting the steady-state. Analysis of the fate of tracer-Fe
59
 in the tissues in terms of a 
linear system of differential equations describing influx, outflux and internal metabolism of 
the system gives a picture of the prevailing “kinematics” of the system, i.e. it describes what 
happens, not the causes and controlling mechanisms. Such a phenomenology is the 
prerequisite for any in-depth systemic description. 
 
 
4.9 Inhomogeneity of compartments 
 
For some important tissues under consideration the assumption of homogeneity is not valid. 
This applies to liver, which consists of parenchymal cells (hepatocytes) and cells of the RES 
(Kupffer-cells). Both types have different iron regulation. Similarly, the murine spleen has 
subcompartments, of erythropoietic and of macrophage cells. Muscle tissue contains a large 
fraction of iron in myoglobin, the turnover of which is different from that of the macrophages 
in muscle. On the whole, the macrophages of RES are spread over a multiplicity of organs 
and change their distribution in inflammation. For the sake of model calculation, 
nevertheless, we treated these organs as compartments. 
 
 
4.10 Numerical parameter estimation 
 
Tracer motion in a steady-state system of homogenous pools (like fig. 2.1) can be modelled 
by ordinary linear differential equations. In theory, the concentration of tracer in these pools 
follows a time course described by superimposed exponentials. In the initially labelled 
central compartment (plasma) the tracer content falls monotonously. In all the other 
compartments, initially void of tracer, the concentration rises to a maximum and then turns 
into a monotonously decreasing phase of recycling into plasma together with outflux out of 
the body. The parameter values of the interconnected system can be obtained as “best fit” 
according to a suitable distance criterion. In practice this estimation process may run into 
two types of difficulty: statistical scatter and redundancy of the parameter space.  
 
The scatter of measured data in most biological systems is considerable and cannot be 
avoided. The reason is individual variation between subjects and the impossibility to exactly 
repeat the same experiment. A statistical model of this situation can, at best, be a close 
approximation to the measured data in the form of an idealized curve. We repeated the 
estimation procedure on sets of artificially generated data which keep the error structure of 
the observed data. The range of parameter variation was revealed in this way. 
 
 
4.11 Interdependence (correlation) of parameter estimates 
 
This is an unavoidable problem of complex biological models. It became clear from the ACE 
analysis (see methods) that our data contained two causes of parameter interdependence: 
insufficient resolution at very early time after tracer injection, and cases of double output of 
tracer back into plasma and out of the body. We overcame these problems by prescribing an 
approximate value of the total plasma clearance calculated from the data of Trinder et al. 
[33]. Furthermore, we replaced double outfluxes by a single lumped one, thus not specifying 
the precise fractional contribution of each pathway (see dotted outflux arrows in fig. 2.1). In 








4.12 Further parameters of the model 
 
The set of clearance- and rate-parameters resulting from the parameterization is given in 
table 3.1. The quality of the fit is satisfactory, as demonstrated in figs. 3.2-3.4. Table 3.1 
contains the most compact representation of the information content of the empirical data. It 
can be used to calculate flux rates 3.3, pool sizes 3.4 and as well as a characteristic 
temporal structure of the system 3.5. Figures 3.5 and 3.6 visualize these quantitative 
estimates. These indirectly derived data indicate ranges (not precise values) of 
system-relevant parameters. Their totality is amenable to physiological interpretation of the 




4.13 Physiological interpretation of the flux model 
 
 
4.14 Systemic iron metabolism can be described as a closed compartment 
system. 
 
The quasi-closed state of the iron system together with the ensuing internal steady-state 
makes into possible to simplify the non-linear structure to a system of ordinary linear 
differential equations. The dynamics of tracer motion depicts the statics of the underlying 
stationary flux-and-pool network. We could build on a number of previous attempts to model 
iron metabolism in this way [9-12, 95], reviews in [6, 7]. The novel aspect here is the detailed 
reversible balance in a network of peripheral tissues that were previously combined ad hoc 
to black boxes. 
 
 
4.15 Iron metabolism is organized as temporal hierarchy on five time 
scales 
 
The importance of time structure has been emphasized by Klipp [96]. We adopted the 
simple time scale defined in eq. 4 (methods section). Analysis of the clearance parameters 
of our experiments (table 3.1, transformed into residence times – table 3.5) and of literature 
data [23, 24, 33] lead to the following grouping of characteristic time periods:  
 Rapid mixing time of the transferrin-bound plasma/ECF pool: below 1 h  
 Total clearance time of plasma iron due mainly to flux into bone marrow, liver and 
muscle: ~ 1 hour.  
 Clearance time of compartments that return tracer into plasma (descending 
branches in figs. 3-4): between ~2 days in the intestinal tract and ~8 days in 
parenchymal organs.  
 Incorporation time into iron-carrying proteins in red blood cells, muscles, 
integument or fat: ~ 1 month. 
 Characteristic life-time of iron molecules in the whole body: approaches 200 days 
in the adult mouse, i.e. its life expectation provided that it had the opportunity to 
acquire a store in the adolescent stage (adequate diet). It is therefore difficult to 
induce iron-depletion anemia in the mouse (contrast to humans). 
 
 




The time hierarchy does not change appreciably between different iron statuses in normal 
mice (confirming the conclusion in [33]). 
 
 
4.16 Iron turnover in the plasma compartment depends on the iron status 
 
The concentration of transferrin-bound plasma iron in plasma is in the range of 100 -200 
μg/dL in the mouse. This is similar to other mammalian species (e.g. [19, 58-61]). The iron 
concentration tends to lower values in iron-deficient and to higher values in iron-loaded mice. 
The iron clearance from plasma defines a half-time of renewal in the range of 1-2 hours, 
again similar for species otherwise as different as Mus musculus and Homo sapiens. Rats 
[61] and dogs [10, 60] are also in the same range. In rats, however, iron deficiency does not 
lower the plasma concentration [61].  
 
 
4.17 Iron distribution into body periphery is a three-level hierarchy of flux 
rates 
 
The initial tracer concentration in plasma becomes rapidly cleared within a few hours after 
administration and stays at a low, but steady value afterwards. This coincides with the 
ascending tracer curves in the peripheral compartments (figs. 3.2-3.4). The initial distribution 
is complete at the first time of measurement (12 h). The position of the maximum fixes the 
time point when plasma tracer is nearly washed out and the periphery begins to return some 
of the previously accumulated tracer iron into the plasma. The continuous decrease of organ 
tracer content begins after 12-24 hours. It is an expression of the fact that “fresh” cellular 
iron is not only stored or channelled into biosynthesis, but also shows an appreciable 
back-flow into the plasma. 
The descending branch of the peripheral tracer curves show that all tissues return the 
radioactivity into the plasma, unless they lose it by desquamation, which is the case for 
intestine and integument. This characteristic pattern proves that iron flux into the periphery 
and reflux into plasma take place simultaneously.  
The quantitative level of all the superimposed fluxes can result only from a deeper analysis 
of the corresponding mathematical model. This analysis yields a set of fractional clearance 
parameters (table 3.2). From these values and by application of the steady-state assumption 
all iron fluxes can be estimated when the iron content of the central compartment is 
available. Data by Trinder et al. [33] contribute an estimate of the total plasma turnover 
clearance rate (table 3.1).  
Three clusters of flux rates may be distinguished (fig. 3.5): 
 flux through the erythron (range of 10 to 20 µg / day per mouse) 
 flux through peripheral compartments with storage function (liver, muscle, 
integument, intestinal tract, kidneys, lungs, heart: 0.5 to 4 µg / day per mouse) 
 flux through organs with slow iron turn-over (testicles, fat, brain) – 0.05-0.08 µg per 
day per mouse. 
 
 
4.18 Share of flux into tissues mirrors transferrin receptor expression 
 
The clearance time of plasma iron is in the range of 1 h, largely independent of the plasma 
iron content and hence the state of the animal’s iron supply. This linear kinetics suggests 
that the total population of TFR1 receptor molecules (responsible for most of the iron 
uptake) works far below its maximal capacity in all cells. The share of radioiron going into 
the body organs reflects this tissue-specific transferrin receptor expression. In contrast to 
the rather stable total clearance time the share of radioiron is dependent on the 




physiological state. In the states of iron depletion and of normal iron supply more than two 
thirds of the plasma iron turnover is directed to the erythropoietic bone marrow and is rapidly 
incorporated into hemoglobin. This is, again, similar to other species [6, 20, 21, 65]. The 
corresponding fraction of tracer iron passes through the immature cells of the erythropoietic 
lineage until it reaches the erythrocyte compartment. 
 
 
4.19 Tracer distribution iron-rich condition reflects the switch-over to the 
storage mode 
 
The flux through the storage pathway into parenchymal organs increases from 25% to 49% 
of plasma turnover (table 3.2; visualized in figures 3.1 and 3.5). Stores are filled up in liver, 




4.20 Tissue cells equilibrate influx and reflux of iron to maintain the iron 
pool 
 
An adult mouse does not grow much during its life-time of ~2 years (if not killed before). Iron 
is taken up by cells with a time characteristic of a few days and must, therefore, be balanced 
by corresponding iron-release. Muscle, fat, heart, lungs, brain and testicles excrete iron into 
plasma or extravascular fluid. The influx of tracer is mediated by transferrin receptor. It is not 
clear from tracer data whether the export is mediated only by the ferroportin channel [18], or 
also via catabolism of heme-bound iron. Ferroportin is dominantly expressed in liver, 
duodenum, and macrophages, and to a lesser extent also in other tissues [97]. Ferroportin 
is not involved in the case of catabolism of whole cells (erythrocytes, intestine, and 
integument). The tracer data as used here cannot distinguish between export of iron and 
loss of whole cells. They yield only an estimate of the total flux out of the compartment. 
 
 
4.21 Intracellular residence time of iron is longer than the life time of its 
protein “carriers" 
 
The life-time of the iron-storage proteins (such as apoferritin/holoferritin) is in the range of 
one day in the liver [98]. Up to 4500 iron ions can be stored in one ferritin molecule [69], and 
become released on proteolytic ferritin degradation. The residence time of iron in the liver 
cell, however, is much longer - in the range of 1-2 weeks (table 3.5). This shows that iron 
released into the very small labile iron pool does not leave the cell, but is re-utilized. This 
slow export conforms to well-known data showing how slowly iron is mobilized from ferritin 
stores to replace iron losses, e.g. after phlebotomy (in men: [66, 99]). Intracellular iron 
stores are no inert long-term reserves, but are continuously turned over within the cell and 
may therefore be directed, in accordance with changing requirements, into the three 
competing pathways (biosynthesis, storage, export). 
 
 
4.22 Readily accessible tissue iron pools are a fraction of the non-heme 
iron 
 
These iron pools are stored in different subcompartments, mainly in non-heme form. The 
iron-loaded liver stores ferritin in the hepatocytes and a less mobilizable (hemosiderin?) 
form in the Kupffer cell [100-102]. The labelled and unlabelled iron data from whole organs 
do not permit to differentiate quantitatively between parenchymal and macrophage iron in 




such mixed cases. Tracer dynamics identifies iron pools that become quickly labelled. Their 
pool sizes have been estimated from the fractional plasma iron turnover and the tissue 
clearance rates (table 3.1 and 3.2). Three groups may be distinguished. Red blood cells 
contain as hemoglobin the largest readily labelled iron pool (~ 300 µg Fe per mouse, about 
50% of total haemoglobin-iron, see calculation in table 3.1). There is a second cluster of 
pools (integument, liver, bone marrow, skeletal muscles, skin), each containing about 
20-40μg Fe. In particular the hepatic iron pool is expandable in iron overload to reach a 
kinetic pool level of ~ 100μg Fe, presumably in ferritin form. A still larger store can possibly 
accumulate on a longer time scale, which is not covered here. There are additional pools 
with an iron content (lungs, kidneys, intestine, heart, and spleen) of about 3µg Fe, which can 
moderately expand up to 4-14µg. Other organs, such as fat, testicles or brain, are not able 
to store more iron in overload. Table 3.7 shows that in some tissues the readily accessible 
pools are only a fraction (6 to 40%) of cellular non-heme iron.  
 
 
4.23 There are two kinetically distinct major iron pools in the mouse body 
 
The total tracer-accessible iron amounts to ~400 µg table 3.6. The residence time in the 
main compartments excluding intestine (table 3.5) is between 5 and 25 days. This 
comprises about 20% of the total iron (i.e. of ~2 mg per 25 g body [24]). The reminder is not 
readily accessible. The residence time of molecules here is ~200 days [23, 24]. 
 
 
4.24 Iron turnover occurs at similar rate in intestine and skin, but 
assignment to iron loss vs. iron reflux is only indirectly estimable 
 
Physiologically iron enters the body via duodenal and (less) small-intestinal absorption in a 
tightly controlled way. It leaves the body by desquamation, exfoliation of epithelial cells, by 
blood losses, and to a lesser extent via bile and urine [103]. The relative amount leaving the 
murine body is, according to literature references, 2 to 5 times larger than in other animals 
and man [24, 34, 58, 73, 74, 103]. A consequence of this higher excretion is that heavy 
iron-load is sometimes difficult to attain in mouse models.  
Net iron losses cannot be measured by the tracer method as applied here. However, the 
fractional clearance rates (table 3.2) yield indirect information on iron fluxes through 
intestine and integument (table 3.3). Iron clearance of the epidermis integument is about 5% 
per day and that of the stomach-intestinal epithelium ca. 36% per day (calculated from table 
3.2). From the fractional uptake from plasma one can calculate influx rates of ~1.7 µg per 
day into epidermis, and a sum of ~1.5 µg per day into intestine plus stomach (all for 
iron-adequate mouse, see table 3.3). These values are about 39% lower and higher in iron 
deficient and iron-load regimes, respectively. The data do not support a calculation of the 
rate of net iron loss through these compartments, because there may be a fraction that is 
recycled into plasma. The iron residence times for intestine are similar to the known 
exfoliation times of epithelium (both 3-5 days), which suggests that the main fraction goes 




4.25 Murine erythrocyte iron turnover has a random elimination 
component together with a lifespan-determined removal component 
 
During one month after administration 60% of the tracer (40% in iron-loaded state) 
accumulates in the red blood cell compartment (figs. 3.2-3.4). The first quick uptake of Fe59 
reflects passage through bone marrow and incorporation into hemoglobin at a steady rate. 




The uptake reaches a saturation phase which is clearly visible in the RBC curve of figs. 3.2 
to 3.4. This behaviour proves the existence of a reflux caused by a random component of 
erythrocyte catabolism independent of the cell age. Without reflux iron would be further 
incorporated even at a very low plasma radioactivity. The erythron cycle transports (table 
3.3) 15;19;14 µg Fe/d into bone marrow in iron-deficient, -adequate, and -loaded animals, 
respectively, of which 12;17;12 µg Fe/d pass through the RBC compartment back via into 
RES into plasma. This turnover rate is quantitatively analogous to ~ 25 mg Fe/d per 70 kg in 
iron-adequate humans [87].  
 
The life span of mouse erythrocytes has been studied in mathematical detail by Horký et al. 
[67]. They also formulated an age-independent linear elimination component acting 
simultaneously with a lifespan-determined senescence process. Our elimination rate 
(between 0.03 and 0.06 d-1) is somewhat higher than obtained in [67] (0.012d-1). However, 
our estimates are not very reliable, as they stem from an indirect deduction. This applies 
also to the size of the “readily accessible” iron pool in red blood cells (300 µg instead of the 
568 µg calculated from the hemoglobin pool of the mouse, see table 3.1). 
 
 
4.26 The spleen is a mixed indicator of erythropoiesis and RES activity 
 
The murine spleen is an erythropoietic organ [64]. Therefore, one subcompartment of iron in 
the spleen is expected to behave similar to iron in the bone marrow. Figs. 3.2 - 3.4 show a 
quick uptake phase in both bone marrow and spleen. The ratio of tracer iron content 
between both organs after 12 h is about 50 to 60 in adequate and iron-rich mice, and 20 in 
iron-deficient animals. Thus, the quantitative contribution of the spleen to total murine 
erythropoiesis is not high. Furthermore, the iron-deficient spleen loses iron as quickly as the 
bone marrow, reflecting the rapid flow into “iron-deficient” erythropoiesis. In contrast to the 
bone marrow, the iron-adequate, and even more so the iron-loaded spleen retains Fe59 for 
long periods. This reflects a storage behaviour which is similar to that of RES cells in the 
liver and elsewhere. The spleen contains 5% and the liver 16% of the whole population of 
macrophages [30]. The RES system serves as scavenger to remove senescent erythrocytes 
together with their hemoglobin and colloidal iron from the circulation [9, 68]. Part of this RES 
iron is rapidly recirculated into plasma, thereby completing the iron-recirculation back to the 
erythrocyte pool. Except in iron deficiency, another part of the RES iron is stored as ferritin 
or hemosiderin [69]. 
 
The quantitative contribution of both spleen compartments to whole body iron turnover is low. 
The spleen is therefore an indicator, but not the main quantitative locus of the total 
erythropoietic and macrophage activity. In iron-deficiency splenic iron clearance is very rapid 
(15 % d-1, see table 3.2), while it is distinctly slower (down to 1.9 % d-1) in iron loaded mice. 
This may reflect distinct differences in the role of the spleen depending on the state of 
iron-repletion. A precise quantitative partition of splenic iron fluxes into a RES- and an 
erythron-fraction would require separation of the cells. 
 
 
4.27 Experimental design for characterizing the iron status and the 
dynamic turnover of the C57BL6 mouse strain. 
 
The C57BL6 mouse is a widely used strain for genetic modifications to address the 
regulatory networks of iron metabolism. Any such transgenic strain needs a characterization 
of its iron kinetics (examples in [104, 105]). This includes a survey of static and dynamic 
characteristics of iron metabolism under the limitations set by thrifty experimental expense. 
The turnover model developed here permits to derive diagnostic requirements for healthy or 
diseased mice, after a steady-state has been established and maintained for the time of at 




least one red blood cell turnover. The following data should be scaled up to the total body 
level: 
 plasma iron steady state, measured by transferrin level and its iron saturation 
 liver and spleen total iron and non-heme iron (may be replaced by plasma ferritin 
as indicator) 
 hemoglobin iron content, if possible red blood cell turnover (as indirect control of 
iron turnover 
 hepcidin and erythropoietin levels  
 plasma iron clearance rate constant (only possible with tracer injection and several 
measurements during the first 12 h) 
 percentage uptake of tracer from duodenum (after a bolus dose into the stomach) 
 organ content of tracer iron, blood-corrected, by several measurements between 
12 and 72 h at least in liver, spleen, red blood cell compartment and bone marrow 
 long-term rate of iron loss. 
The biochemical parameters yield a survey of the static of iron metabolism and its 
steady-state level. Ferrokinetics yields the fluxes. This full programme can be reduced, if in 
a particular situation preliminary analysis of data and their comparison with the 




4.28 Simulated Experiments – Perturbation and Transgenic 
Reconstruction 
 
Given knowledge on the stoichiometric network structure, the most important regulatory 
signal (IRP/IRE system), hepcidin and erythropoetin) and the flux parameters estimated 
from the distribution dynamics of radioactive iron in the mouse body, it is possible to draft a 
kinetic model of cellular metabolism integrated to the whole organism. The important 
parameters of this system have been chosen as to reproduce the flux pattern into and out of 
the periphery of the body. The intracellular parameters that are not available have been set 
at normalized standard values, relative to the normal state of the adult mouse.  
 
We have done simulation runs on the resulting system of balance equations. Extracts of 
calibration experiments in silico have been presented and discussed in the “results” section. 
Studies are at present under way to built a specified model version that takes into account 
the results of ongoing transgenic cpmstructions in the labos of Profs. Hentze, Muckenthaler 
and Schümann.  
 
 
4.29 Conclusion and Outlook 
 
This mathematical model presented a comprehensive physiological picture of mice under 
three different diets with varying iron contents. We could assess which parameters will 
change under dietary perturbations and study in quantitative terms when those changes 
take place. We have devised a simulation model of the iron metabolism of the mouse that 
integrates the various tissues and cell types in the form of a system of differential equations. 
We chose the parameters of this model, partly by fitting to ferrokinetic tracer data, partly by 
adopting biochemical data, and partly by formulating black boxes of kinetic behavior and of 
regulatory signals, using the established general theory of metabolism as source of first 
principles. This is a different from the recent review paper of Hower et al. [106] where they 
explained many known molecular mechanisms of iron metabolism and finished offering a 
SBML layout, but without equations or simulations.The kinetic model of the reference state 
reproduces in a semi-quantitative way the main features of the iron status of the mouse in 




several conditions, including transgenic constructs.  
 
Future studies could profit from the model and the results presented here. One idea would 
be to perform the same type of ferrokinetic studies in genetically constructed mice, either 
knock-out, knock-in or conditional knock-out mice. Adapting the parameter structure of our 
model to these artificial conditions and carrying out biochemical measurements of the iron 
status of these animals one will obtain a still more precise quantitative description of the 
system. 
 
An obvious extension of the work would be an attempt to transform the model to the human 
organism. This can of course not been a simple up-scaling everything by a factor of 3000 or 
so. There is ample literature data on the iron metabolism of man and its physiological and 
pathological perturbations. There is hope that such a quantified global computer model 
could be of great help in the diagnostics and therapy planning of iron disorders. 
 





Table 1: Iron-adequate Diet in healthy Mice - Tracer Iron Content of Body Organs after intravenous Injection  
Organ / Time 0.5 Day 1 Day 4 Days 7 Days 14 Days 28 Days 
Duodenum 0.555 ± 0.222 0.349 ± 0.148 0.207 ± 0.055 0.052 ± 0.002 0.085 ± 0.032 0.047 ± 0.019
Liver 0.849 ± 0.249 0.706 ± 0.317 0.664 ± 0.105 0.547 ± 0.076 0.432 ± 0.199 0.258 ± 0.075
Spleen 0.831 ± 0.196 1.153 ± 0.471 0.619 ± 0.517 0.582 ± 0.452 0.398 ± 0.111 0.438 ± 0.114
Bones 1.937 ± 0.587 0.720 ± 0.247 0.381 ± 0.085 0.282 ± 0.083 0.251 ± 0.163 0.124 ± 0.031
Heart 0.520 ± 0.090 0.260 ± 0.040 0.400 ± 0.170 0.400 ± 0.330 0.370 ± 0.260 0.230 ± 0.080
Kidneys 0.500 ± 0.200 0.310 ± 0.160 0.350 ± 0.120 0.170 ± 0.050 0.170 ± 0.150 0.180 ± 0.170
Lungs 0.780 ± 0.480 1.170 ± 1.160 0.490 ± 0.110 0.330 ± 0.420 0.330 ± 0.120 0.300 ± 0.120
Stomach 0.240 ± 0.160 0.180 ± 0.100 0.100 ± 0.030 0.040 ± 0.020 0.060 ± 0.030 0.050 ± 0.030
Integument 0.150 ± 0.190 0.100 ± 0.040 0.140 ± 0.040 0.150 ± 0.190 0.180 ± 0.070 0.070 ± 0.060
Fat 0.040 ± 0.020 0.060 ± 0.030 0.050 ± 0.030 0.110 ± 0.100 0.050 ± 0.050 0.010 ± 0.010
Muscle 0.060 ± 0.030 0.030 ± 0.010 0.030 ± 0.010 0.080 ± 0.100 0.010 ± 0.010 0.020 ± 0.010
Brain 0.030 ± 0.010 0.020 ± 0.010 0.030 ± 0.010 0.020 ± 0.100 0.030 ± 0.020 0.020 ± 0.000
Testes 0.080 ± 0.020 0.080 ± 0.010 0.090 ± 0.020 0.070 ± 0.040 0.080 ± 0.030 0.040 ± 0.010
Plasma 0.087 ± 0.048 0.015 ± 0.007 0.011 ± 0.007 0.005 ± 0.001 0.013 ± 0.001 0.016 ± 0.011
Blood 0.860 ± 0.380 1.730 ± 0.640 2.220 ± 0.600 1.780 ± 0.490 1.760 ± 0.380 1.880 ± 0.240
Intestine 0.370 ± 0.220 0.300 ± 0.130 0.160 ± 0.100 0.050 ± 0.020 0.040 ± 0.070 0.030 ± 0.080
Ileum 0.490 ± 0.280 0.350 ± 0.120 0.140 ± 0.040 0.040 ± 0.010 0.040 ± 0.120 0.030 ± 0.100
Caecum 0.310 ± 0.170 0.320 ± 0.140 0.230 ± 0.170 0.040 ± 0.020 0.030 ± 0.010 0.020 ± 0.100
Colon 0.300 ± 0.190 0.220 ± 0.130 0.120 ± 0.040 0.060 ± 0.030 0.040 ± 0.020 0.040 ± 0.020
 
Data (nmoles Fe59 per g wet weight after an intravenous injection of tracer) are from tables 3 and 4 of [27]. They apply to organ content after correction for residual blood 
content not removed by perfusion.  
 
The intestinal content was calculated as mean ± standard deviation (rounded to 2 digits) from the values of ileum/caecum/colon (standard deviation of intestine: root of the 
mean of the three variances). 
 
For plasma and whole blood data were taken from fig. 2 of [27]. 
The tracer content in the original data was normalized to the iron concentration in the initial dose of administered radioactivity.  
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Table 2: Iron-deficient Diet in healthy Mice - Tracer Iron Content of Body Organs after intravenous Injection  
Organ / Time 0.5 DAY 1 DAY 4 DAYS 7 DAYS 14 DAYS 28 DAYS 
Duodenum 0.282 ± 0.130 0.133 ± 0.036 0.167 ± 0.046 0.069 ± 0.028 0.093 ± 0.064 0.081 ± 0.030
Liver 0.559 ± 0.214 0.494 ± 0.276 0.539 ± 0.184 0.259 ± 0.056 0.230 ± 0.110 0.108 ± 0.027
Spleen 1.279 ± 0.346 0.431 ± 0.303 0.085 ± 0.143 -0.064 ± 0.105 -0.151 ± 0.165 -0.062 ± 0.077
Bones 1.053 ± 0.265 0.221 ± 0.101 0.165 ± 0.062 0.096 ± 0.028 0.041 ± 0.026 0.064 ± 0.012
Heart 0.330 ± 0.120 0.270 ± 0.180 0.370 ± 0.090 0.330 ± 0.230 0.260 ± 0.090 0.410 ± 0.140
Kidneys 0.360 ± 0.190 0.290 ± 0.150 0.360 ± 0.090 0.150 ± 0.090 0.150 ± 0.160 0.190 ± 0.050
Lungs 0.890 ± 0.820 2.600 ± 0.750 1.220 ± 0.950 0.280 ± 0.140 0.480 ± 0.240 0.160 ± 0.090
Stomach 0.210 ± 0.120 0.120 ± 0.080 0.150 ± 0.050 0.100 ± 0.070 0.080 ± 0.040 0.090 ± 0.030
Integument 0.130 ± 0.040 0.100 ± 0.040 0.170 ± 0.090 0.110 ± 0.070 0.090 ± 0.050 0.190 ± 0.050
Fat 0.040 ± 0.010 0.060 ± 0.040 0.050 ± 0.030 0.060 ± 0.060 0.040 ± 0.030 0.030 ± 0.010
Muscle 0.030 ± 0.010 0.040 ± 0.040 0.030 ± 0.020 0.030 ± 0.020 0.020 ± 0.020 0.050 ± 0.010
Brain 0.020 ± 0.001 0.020 ± 0.010 0.030 ± 0.010 0.040 ± 0.020 0.040 ± 0.010 0.040 ± 0.010
Testes 0.070 ± 0.010 0.050 ± 0.020 0.070 ± 0.020 0.080 ± 0.030 0.100 ± 0.060 0.070 ± 0.020
Plasma 0.080 ± 0.046 0.041 ± 0.030 0.017 ± 0.004 0.017 ± 0.019 0.012 ± 0.008 0.017 ± 0.015
Blood 0.880 ± 0.160 2.000 ± 0.890 2.640 ± 0.500 2.720 ± 0.780 2.920 ± 1.040 2.760 ± 0.320
Intestine 0.337 ± 0.167 0.223 ± 0.104 0.170 ± 0.072 0.093 ± 0.098 0.053 ± 0.027 0.037 ± 0.060
Ileum 0.360 ± 0.180 0.270 ± 0.050 0.140 ± 0.090 0.060 ± 0.060 0.050 ± 0.020 0.040 ± 0.020





For plasma and whole blood data were taken from fig. 2 of [27]. 
The tracer content in the original data was normalized to the iron concentration in the initial dose of administered radioactivity. 
 
 
Three values (spleen, iron-deficient at 7, 14, 28 days) were slightly lower than zero within a standard deviation interval covering the zero value. This is due to 
over-correction of blood-content (see methods section “Organ mass of the whole body”) in the original publication. 
 




Table 3: Iron-loaded Diet in healthy Mice - Tracer Iron Content of Body Organs after intravenous Injection  
Organ / Time 0.5 Day 1 Day 4 Days 7 Days 14 Days 28 Days 
Duodenum 0.266 ± 0.140 0.469 ± 0.103 0.291 ± 0.221 0.074 ± 0.038 0.105 ± 0.092 0.103 ± 0.090
Liver 0.769 ± 0.257 2.332 ± 0.406 1.505 ± 0.763 0.840 ± 0.276 0.895 ± 0.586 0.898 ± 0.238
Spleen 0.526 ± 0.352 0.986 ± 0.511 0.633 ± 0.007 0.709 ± 0.344 0.632 ± 0.102 0.928 ± 0.217
Bones 1.062 ± 0.368 0.686 ± 0.203 0.234 ± 0.047 0.191 ± 0.066 0.304 ± 0.094 0.176 ± 0.034
Heart 0.670 ± 0.200 0.810 ± 0.280 0.640 ± 0.170 0.740 ± 0.430 0.300 ± 0.150 0.270 ± 0.180
Kidneys 0.750 ± 0.530 1.700 ± 0.460 1.000 ± 0.900 0.470 ± 0.260 0.410 ± 0.300 0.350 ± 0.200
Lungs 1.410 ± 1.110 1.340 ± 0.320 1.460 ± 1.350 3.050 ± 0.800 1.260 ± 1.250 0.800 ± 0.340
Stomach 0.230 ± 0.240 0.620 ± 0.260 0.220 ± 0.160 0.140 ± 0.120 0.110 ± 0.100 0.120 ± 0.080
Integument 0.100 ± 0.050 0.200 ± 0.040 0.080 ± 0.060 0.100 ± 0.050 0.090 ± 0.040 0.090 ± 0.030
Fat 0.040 ± 0.020 0.090 ± 0.040 0.060 ± 0.040 0.070 ± 0.030 0.070 ± 0.010 0.020 ± 0.020
Muscle 0.040 ± 0.020 0.080 ± 0.030 0.040 ± 0.020 0.040 ± 0.010 0.040 ± 0.020 0.020 ± 0.010
Brain 0.010 ± 0.010 0.020 ± 0.001 0.010 ± 0.010 0.020 ± 0.010 0.030 ± 0.010 0.020 ± 0.001
Testes 0.100 ± 0.120 0.070 ± 0.020 0.040 ± 0.010 0.060 ± 0.010 0.070 ± 0.030 0.050 ± 0.010
Plasma 0.085 ± 0.024 0.026 ± 0.013 0.006 ± 0.002 0.004 ± 0.001 0.007 ± 0.005 0.013 ± 0.005
Blood 0.240 ± 0.052 0.520 ± 0.164 0.800 ± 0.080 1.200 ± 0.180 1.840 ± 0.400 1.280 ± 0.256
Intestine 0.233 ± 0.145 0.387 ± 0.137 0.167 ± 0.131 0.083 ± 0.054 0.077 ± 0.034 0.063 ± 0.044
Ileum 0.250 ± 0.160 0.360 ± 0.140 0.150 ± 0.110 0.060 ± 0.050 0.040 ± 0.010 0.040 ± 0.010
Caecum 0.220 ± 0.110 0.400 ± 0.140 0.170 ± 0.130 0.080 ± 0.050 0.080 ± 0.030 0.060 ± 0.030
Colon 0.230 ± 0.160 0.400 ± 0.130 0.180 ± 0.150 0.110 ± 0.060 0.110 ± 0.050 0.090 ± 0.070
 
 
Data (nmoles Fe59 per g wet weight after an intravenous injection of tracer) are from tables 3 and 4 of [27]. They apply to organ content after correction for residual blood content not removed 
by perfusion.  
 
The intestinal content was calculated as mean ± standard deviation (rounded to 2 digits) from the values of ileum/caecum/colon (standard deviation of intestine: root of the mean of the three 
variances). 
  
For plasma and whole blood data were taken from fig. 2 of [27]. 
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